{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:00:51Z","timestamp":1790420451711,"version":"4.1.0"},"reference-count":398,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s12035-021-02555-y","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T19:04:30Z","timestamp":1634324670000},"page":"191-233","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases"],"prefix":"10.1007","volume":"59","author":[{"given":"Della Grace Thomas","family":"Parambi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid Saad","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seetha","family":"Harilal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaber El-Saber","family":"Batiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5934-5201","authenticated-orcid":false,"given":"Nat\u00e1lia","family":"Cruz-Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omnia","family":"Magdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arafa","family":"Musa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dibya Sundar","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijo","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,15]]},"reference":[{"key":"2555_CR1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.neuropharm.2012.03.004","volume":"69","author":"MS Weinberg","year":"2013","unstructured":"Weinberg MS, Samulski RJ, McCown TJ (2013) Adeno-associated virus (AAV) gene therapy for neurological disease. Neuropharmacology 69:82\u201388. https:\/\/doi.org\/10.1016\/j.neuropharm.2012.03.004","journal-title":"Neuropharmacology"},{"key":"2555_CR2","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.molmed.2015.06.001","volume":"21","author":"DM O\u2019Connor","year":"2015","unstructured":"O\u2019Connor DM, Boulis NM (2015) Gene therapy for neurodegenerative diseases. Trends Mol Med 21:504\u2013512. https:\/\/doi.org\/10.1016\/j.molmed.2015.06.001","journal-title":"Trends Mol Med"},{"key":"2555_CR3","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.3389\/fnins.2020.580179","volume":"14","author":"R Martier","year":"2020","unstructured":"Martier R, Konstantinova P (2020) Gene Therapy for neurodegenerative diseases: slowing down the ticking clock. Front Neurosci 14:1002","journal-title":"Front Neurosci"},{"key":"2555_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.brainresbull.2020.03.018","volume":"160","author":"S Harilal","year":"2020","unstructured":"Harilal S, Jose J, Kumar R, Unnikrishnan MK, Uddin MS, Mathew GE, Pratap R, Marathakam A, et al (2020) Revisiting the Blood-brain barrier: a hard nut to crack in the transportation of drug molecules. Brain Res Bull 160:121\u2013140","journal-title":"Brain Res Bull"},{"key":"2555_CR5","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41594-019-0263-5","volume":"26","author":"CE Holt","year":"2019","unstructured":"Holt CE, Martin KC, Schuman EM (2019) Local translation in neurons: visualization and function. Nat Struct Mol Biol 26:557\u2013566","journal-title":"Nat Struct Mol Biol"},{"key":"2555_CR6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.nec.2009.04.004","volume":"20","author":"RM Richardson","year":"2009","unstructured":"Richardson RM, Varenika V, Forsayeth JR, Bankiewicz KS (2009) Future applications: gene therapy. Neurosurg Clin N Am 20:205\u2013210. https:\/\/doi.org\/10.1016\/j.nec.2009.04.004","journal-title":"Neurosurg Clin N Am"},{"key":"2555_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11682-015-9365-9","volume":"9","author":"JD Van Horn","year":"2015","unstructured":"Van Horn JD, Pelphrey KA (2015) Neuroimaging of the developing brain. Brain Imaging Behav 9:1\u20134. https:\/\/doi.org\/10.1007\/s11682-015-9365-9","journal-title":"Brain Imaging Behav"},{"key":"2555_CR8","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/nrd.2018.110","volume":"17","author":"BE Deverman","year":"2018","unstructured":"Deverman BE, Ravina BM, Bankiewicz KS, Paul SM, Sah DW (2018) Gene therapy for neurological disorders: progress and prospects. Nat Rev Drug Discov 17:641\u2013659","journal-title":"Nat Rev Drug Discov"},{"key":"2555_CR9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrneurol.2013.56","volume":"9","author":"M Simonato","year":"2013","unstructured":"Simonato M, Bennett J, Boulis NM, Castro MG, Fink DJ, Goins WF, Gray SJ, Lowenstein PR, et al (2013) Progress in gene therapy for neurological disorders. Nat Rev Neurol 9:277\u2013291. https:\/\/doi.org\/10.1038\/nrneurol.2013.56","journal-title":"Nat Rev Neurol"},{"key":"2555_CR10","doi-asserted-by":"publisher","first-page":"e3015","DOI":"10.1002\/jgm.3015","volume":"20","author":"SL Ginn","year":"2018","unstructured":"Ginn SL, Amaya AK, Alexander IE, Edelstein M, Abedi MR (2018) Gene Therapy clinical trials worldwide to 2017: an update. J. Gene Med. 20:e3015","journal-title":"J. Gene Med."},{"key":"2555_CR11","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s13311-018-00694-0","volume":"16","author":"V Sudhakar","year":"2019","unstructured":"Sudhakar V, Richardson RM (2019) Gene therapy for neurodegenerative diseases. Neurother J Am Soc Exp Neurother 16:166\u2013175. https:\/\/doi.org\/10.1007\/s13311-018-00694-0","journal-title":"Neurother J Am Soc Exp Neurother"},{"issue":"12","key":"2555_CR12","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.tips.2020.09.010","volume":"41","author":"YA Sidorova","year":"2020","unstructured":"Sidorova YA, Saarma M (2020) Can growth factors cure Parkinson\u2019s disease? Trends Pharmacol. Sci. 41(12):909\u2013922","journal-title":"Trends Pharmacol. Sci."},{"key":"2555_CR13","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/j.stemcr.2018.03.024","volume":"10","author":"AA Akhtar","year":"2018","unstructured":"Akhtar AA, Gowing G, Kobritz N, Savinoff SE, Garcia L, Saxon D, Cho N, Kim G, et al (2018) Inducible expression of GDNF in transplanted IPSC-derived neural progenitor cells. Stem Cell Rep 10:1696\u20131704","journal-title":"Stem Cell Rep"},{"key":"2555_CR14","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.stem.2020.01.010","volume":"26","author":"CW Gantner","year":"2020","unstructured":"Gantner CW, de Luzy IR, Kauhausen JA, Moriarty N, Niclis JC, Bye CR, Penna V, Hunt CP, et al (2020) Viral delivery of GDNF promotes functional integration of human stem cell grafts in Parkinson\u2019s disease. Cell Stem Cell 26:511\u2013526","journal-title":"Cell Stem Cell"},{"key":"2555_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/bs.pbr.2016.11.003","volume":"230","author":"G Gowing","year":"2017","unstructured":"Gowing G, Svendsen S, Svendsen CN (2017) Ex vivo gene therapy for the treatment of neurological disorders. Prog Brain Res 230:99\u2013132","journal-title":"Prog Brain Res"},{"key":"2555_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.trsl.2015.09.008","volume":"168","author":"N Savi\u0107","year":"2016","unstructured":"Savi\u0107 N, Schwank G (2016) Advances in therapeutic CRISPR\/Cas9 genome editing. Transl Res 168:15\u201321","journal-title":"Transl Res"},{"key":"2555_CR17","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/sj.gt.3302679","volume":"13","author":"S Behrstock","year":"2006","unstructured":"Behrstock S, Ebert A, McHugh J, Vosberg S, Moore J, Schneider B, Capowski E, Hei D, et al (2006) Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates. Gene Ther 13:379\u2013388","journal-title":"Gene Ther"},{"key":"2555_CR18","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1089\/hum.2005.16.509","volume":"16","author":"SM Klein","year":"2005","unstructured":"Klein SM, Behrstock S, McHugh J, Hoffmann K, Wallace K, Suzuki M, Aebischer P, Svendsen CN (2005) GDNF Delivery using human neural progenitor cells in a rat model of ALS. Hum Gene Ther 16:509\u2013521","journal-title":"Hum Gene Ther"},{"key":"2555_CR19","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrg2985","volume":"12","author":"L Naldini","year":"2011","unstructured":"Naldini L (2011) Ex Vivo Gene Transfer and correction for cell-based therapies. Nat Rev Genet 12:301\u2013315","journal-title":"Nat Rev Genet"},{"key":"2555_CR20","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrg2988","volume":"12","author":"F Mingozzi","year":"2011","unstructured":"Mingozzi F, High KA (2011) Therapeutic in vivo gene transfer for genetic disease using AAV: Progress and challenges. Nat Rev Genet 12:341\u2013355","journal-title":"Nat Rev Genet"},{"key":"2555_CR21","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1517\/14712598.2015.995086","volume":"15","author":"Y Liu","year":"2015","unstructured":"Liu Y, Wang D-A (2015) Viral vector-mediated transgenic cell therapy in regenerative medicine: safety of the process. Expert Opin Biol Ther 15:559\u2013567","journal-title":"Expert Opin Biol Ther"},{"key":"2555_CR22","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.5966\/sctm.2014-0121","volume":"3","author":"R Barrett","year":"2014","unstructured":"Barrett R, Ornelas L, Yeager N, Mandefro B, Sahabian A, Lenaeus L, Targan SR, Svendsen CN, et al (2014) Reliable generation of induced pluripotent stem cells from human lymphoblastoid cell lines. Stem Cells Transl Med 3:1429\u20131434","journal-title":"Stem Cells Transl Med"},{"key":"2555_CR23","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/nature08797","volume":"463","author":"T Vierbuchen","year":"2010","unstructured":"Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, S\u00fcdhof TC, Wernig M (2010) Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463:1035\u20131041","journal-title":"Nature"},{"key":"2555_CR24","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1523\/JNEUROSCI.12-07-02849.1992","volume":"12","author":"MD Kawaja","year":"1992","unstructured":"Kawaja MD, Rosenberg MB, Yoshida K, Gage FH (1992) Somatic gene transfer of nerve growth factor promotes the survival of axotomized septal neurons and the regeneration of their axons in adult rats. J Neurosci 12:2849\u20132864","journal-title":"J Neurosci"},{"issue":"4","key":"2555_CR25","first-page":"305","volume":"3","author":"M Tuszynski","year":"1996","unstructured":"Tuszynski M, Roberts J, Senut M, U HS, Gage F (1996) Gene therapy in the adult primate brain: intraparenchymal grafts of cells genetically modified to produce nerve growth factor prevent cholinergic neuronal degeneration. Gene Ther. 3(4):305\u2013314","journal-title":"Gene Ther."},{"key":"2555_CR26","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.exphem.2008.03.004","volume":"36","author":"A Sorrentino","year":"2008","unstructured":"Sorrentino A, Ferracin M, Castelli G, Biffoni M, Tomaselli G, Baiocchi M, Fatica A, Negrini M, et al (2008) Isolation and characterization of CD146+ multipotent mesenchymal stromal cells. Exp Hematol 36:1035\u20131046","journal-title":"Exp Hematol"},{"key":"2555_CR27","doi-asserted-by":"publisher","first-page":"26417","DOI":"10.3390\/ijms161125961","volume":"16","author":"T Amemori","year":"2015","unstructured":"Amemori T, Jendelova P, Ruzicka J, Urdzikova LM, Sykova E (2015) Alzheimer\u2019s disease: mechanism and approach to cell therapy. Int J Mol Sci 16:26417\u201326451","journal-title":"Int J Mol Sci"},{"key":"2555_CR28","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2174\/1574888X09666140923101110","volume":"9","author":"T Tanna","year":"2014","unstructured":"Tanna T, Sachan V (2014) Mesenchymal stem cells: potential in treatment of neurodegenerative diseases. Curr Stem Cell Res Ther 9:513\u2013521","journal-title":"Curr Stem Cell Res Ther"},{"key":"2555_CR29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0165-0270(98)00126-5","volume":"85","author":"CN Svendsen","year":"1998","unstructured":"Svendsen CN, ter Borg MG, Armstrong RJ, Rosser AE, Chandran S, Ostenfeld T, Caldwell MA (1998) A new method for the rapid and long term growth of human neural precursor cells. J Neurosci Methods 85:141\u2013152","journal-title":"J Neurosci Methods"},{"key":"2555_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0166-2236(03)00031-6","volume":"26","author":"RM Seaberg","year":"2003","unstructured":"Seaberg RM, van der Kooy D (2003) Stem and progenitor cells: the premature desertion of rigorous definitions. Trends Neurosci 26:125\u2013131","journal-title":"Trends Neurosci"},{"key":"2555_CR31","doi-asserted-by":"publisher","first-page":"l1145","DOI":"10.1126\/science.282.5391.1145","volume":"282","author":"JA Thomson","year":"1998","unstructured":"Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM (1998) Embryonic stem cell lines derived from human blastocysts. Science 282:l1145-1147","journal-title":"Science"},{"key":"2555_CR32","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.addr.2014.11.011","volume":"82","author":"I de Miguel-Beriain","year":"2015","unstructured":"de Miguel-Beriain I (2015) The Ethics of Stem Cells Revisited. Adv Drug Deliv Rev 82:176\u2013180","journal-title":"Adv Drug Deliv Rev"},{"key":"2555_CR33","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.stemcr.2013.08.007","volume":"1","author":"A Morizane","year":"2013","unstructured":"Morizane A, Doi D, Kikuchi T, Okita K, Hotta A, Kawasaki T, Hayashi T, Onoe H, et al (2013) Direct Comparison of autologous and allogeneic transplantation of IPSC-derived neural cells in the brain of a nonhuman primate. Stem Cell Rep 1:283\u2013292","journal-title":"Stem Cell Rep"},{"key":"2555_CR34","doi-asserted-by":"publisher","first-page":"R32","DOI":"10.1093\/hmg\/ddt379","volume":"22","author":"CN Svendsen","year":"2013","unstructured":"Svendsen CN (2013) Back to the future: how human induced pluripotent stem cells will transform regenerative medicine. Hum Mol Genet 22:R32\u2013R38","journal-title":"Hum Mol Genet"},{"key":"2555_CR35","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/cgt.2015.68","volume":"23","author":"H Mirzaei","year":"2016","unstructured":"Mirzaei H, Sahebkar A, Jaafari MR, Hadjati J, Javanmard SH, Mirzaei HR, Salehi R (2016) PiggyBac as a novel vector in cancer gene therapy: current perspective. Cancer Gene Ther 23:45\u201347","journal-title":"Cancer Gene Ther"},{"key":"2555_CR36","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.tibtech.2015.06.009","volume":"33","author":"LE Woodard","year":"2015","unstructured":"Woodard LE, Wilson MH (2015) PiggyBac-Ing models and new therapeutic strategies. Trends Biotechnol 33:525\u2013533","journal-title":"Trends Biotechnol"},{"key":"2555_CR37","doi-asserted-by":"publisher","first-page":"e265","DOI":"10.1038\/emm.2016.111","volume":"48","author":"A Eid","year":"2016","unstructured":"Eid A, Mahfouz MM (2016) Genome editing: the road of CRISPR\/Cas9 from bench to clinic. Exp Mol Med 48:e265\u2013e265","journal-title":"Exp Mol Med"},{"key":"2555_CR38","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00439-016-1699-x","volume":"135","author":"C-Y Park","year":"2016","unstructured":"Park C-Y, Lee DR, Sung JJ, Kim D-W (2016) Genome-Editing technologies for gene correction of hemophilia. Hum Genet 135:977\u2013981","journal-title":"Hum Genet"},{"key":"2555_CR39","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/nrg.2016.28","volume":"17","author":"SQ Tsai","year":"2016","unstructured":"Tsai SQ, Joung JK (2016) Defining and improving the genome-wide specificities of CRISPR\u2013Cas9 nucleases. Nat Rev Genet 17:300\u2013312","journal-title":"Nat Rev Genet"},{"key":"2555_CR40","doi-asserted-by":"publisher","first-page":"136","DOI":"10.14802\/jmd.16029","volume":"9","author":"W Im","year":"2016","unstructured":"Im W, Moon J, Kim M (2016) Applications of CRISPR\/Cas9 for gene editing in hereditary movement disorders. J Mov Disord 9:136","journal-title":"J Mov Disord"},{"key":"2555_CR41","doi-asserted-by":"publisher","first-page":"12744LP","DOI":"10.1073\/pnas.94.24.12744","volume":"94","author":"MA Kay","year":"1997","unstructured":"Kay MA, Liu D, Hoogerbrugge PM (1997) Gene therapy. Proc. Natl. Acad. Sci. 94:12744LP \u2013 12746. https:\/\/doi.org\/10.1073\/pnas.94.24.12744","journal-title":"Proc. Natl. Acad. Sci."},{"key":"2555_CR42","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3389\/fphar.2019.00724","volume":"10","author":"S Ingusci","year":"2019","unstructured":"Ingusci S, Verlengia G, Soukupova M, Zucchini S, Simonato M (2019) Gene Therapy tools for brain diseases. Front Pharmacol 10:724","journal-title":"Front Pharmacol"},{"key":"2555_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1758-3284-1-7","volume":"1","author":"EJ Shillitoe","year":"2009","unstructured":"Shillitoe EJ (2009) Gene Therapy: The End of the Rainbow? Head Neck Oncol 1:7. https:\/\/doi.org\/10.1186\/1758-3284-1-7","journal-title":"Head Neck Oncol"},{"key":"2555_CR44","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1113\/expphysiol.2004.028191","volume":"90","author":"AG Teschemacher","year":"2005","unstructured":"Teschemacher AG, Wang S, Lonergan T, Duale H, Waki H, Paton JFR, Kasparov S (2005) Targeting specific neuronal populations using adeno- and lentiviral vectors: applications for imaging and studies of cell function. Exp Physiol 90:61\u201369. https:\/\/doi.org\/10.1113\/expphysiol.2004.028191","journal-title":"Exp Physiol"},{"key":"2555_CR45","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3389\/fnmol.2014.00050","volume":"7","author":"M Bourdenx","year":"2014","unstructured":"Bourdenx M, Dutheil N, Bezard E, Dehay B (2014) Systemic gene delivery to the central nervous system using adeno-associated virus. Front Mol Neurosci 7:50","journal-title":"Front Mol Neurosci"},{"key":"2555_CR46","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3390\/diseases6030074","volume":"6","author":"S Artusi","year":"2018","unstructured":"Artusi S, Miyagawa Y, Goins WF, Cohen JB, Glorioso JC (2018) Herpes Simplex virus vectors for gene transfer to the central nervous system. Dis Basel Switz 6:74. https:\/\/doi.org\/10.3390\/diseases6030074","journal-title":"Dis Basel Switz"},{"key":"2555_CR47","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.1073\/pnas.050581197","volume":"97","author":"BL Davidson","year":"2000","unstructured":"Davidson BL, Stein CS, Heth JA, Martins I, Kotin RM, Derksen TA, Zabner J, Ghodsi A, et al (2000) Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc Natl Acad Sci U S A 97:3428\u20133432. https:\/\/doi.org\/10.1073\/pnas.050581197","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2555_CR48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/oxfordjournals.bmb.a072951","volume":"51","author":"EJ Kremer","year":"1995","unstructured":"Kremer EJ, Perricaudet M (1995) Adenovirus and Adeno-associated virus mediated gene transfer. Br Med Bull 51:31\u201344. https:\/\/doi.org\/10.1093\/oxfordjournals.bmb.a072951","journal-title":"Br Med Bull"},{"key":"2555_CR49","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/S0959-4388(96)80088-2","volume":"6","author":"RS Slack","year":"1996","unstructured":"Slack RS, Miller FD (1996) Viral vectors for modulating gene expression in neurons. Curr Opin Neurobiol 6:576\u2013583. https:\/\/doi.org\/10.1016\/S0959-4388(96)80088-2","journal-title":"Curr Opin Neurobiol"},{"key":"2555_CR50","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/sj.gt.3302545","volume":"12","author":"AR Frampton","year":"2005","unstructured":"Frampton AR, Goins WF, Nakano K, Burton EA, Glorioso JC (2005) HSV Trafficking and development of gene therapy vectors with applications in the nervous system. Gene Ther 12:891\u2013901","journal-title":"Gene Ther"},{"key":"2555_CR51","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/978-1-62703-272-8_12","volume-title":"Applications of Biotechnology in Neurology","author":"KK Jain","year":"2013","unstructured":"Jain KK (2013) Gene therapy of neurological disorders. Applications of Biotechnology in Neurology. Springer, Berlin, pp 383\u2013476"},{"key":"2555_CR52","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","volume":"18","author":"D Wang","year":"2019","unstructured":"Wang D, Tai PW, Gao G (2019) Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Discov 18:358\u2013378","journal-title":"Nat Rev Drug Discov"},{"key":"2555_CR53","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2174\/187221412799015245","volume":"6","author":"S Ortolano","year":"2012","unstructured":"Ortolano S, Spuch C, Navarro C (2012) Present and future of adeno associated virus based gene therapy approaches. Recent Pat Endocr Metab Immune Drug Discov. 6:47\u201366","journal-title":"Recent Pat Endocr Metab Immune Drug Discov."},{"key":"2555_CR54","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","volume":"31","author":"MF Naso","year":"2017","unstructured":"Naso MF, Tomkowicz B, Perry WL, Strohl WR (2017) Adeno-associated virus (AAV) as a vector for gene therapy. BioDrugs 31:317\u2013334","journal-title":"BioDrugs"},{"key":"2555_CR55","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1517\/14712598.2012.681463","volume":"12","author":"RD Dayton","year":"2012","unstructured":"Dayton RD, Wang DB, Klein RL (2012) The advent of AAV9 expands applications for brain and spinal cord gene delivery. Expert Opin Biol Ther 12:757\u2013766","journal-title":"Expert Opin Biol Ther"},{"key":"2555_CR56","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fnana.2019.00093","volume":"13","author":"L Haery","year":"2019","unstructured":"Haery L, Deverman BE, Matho KS, Cetin A, Woodard K, Cepko C, Guerin KI, Rego MA, et al (2019) Adeno-associated virus technologies and methods for targeted neuronal manipulation. Front Neuroanat 13:93","journal-title":"Front Neuroanat"},{"key":"2555_CR57","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.neuron.2016.09.021","volume":"92","author":"DGR Tervo","year":"2016","unstructured":"Tervo DGR, Hwang B-Y, Viswanathan S, Gaj T, Lavzin M, Ritola KD, Lindo S, Michael S, et al (2016) A Designer AAV variant permits efficient retrograde access to projection neurons. Neuron 92:372\u2013382","journal-title":"Neuron"},{"key":"2555_CR58","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1038\/sj.gt.3302554","volume":"12","author":"G Liu","year":"2005","unstructured":"Liu G, Martins IH, Chiorini JA, Davidson BL (2005) Adeno-associated virus type 4 (AAV4) targets ependyma and astrocytes in the subventricular zone and RMS. Gene Ther 12:1503\u20131508","journal-title":"Gene Ther"},{"key":"2555_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2006.09.042","volume":"1122","author":"S Li","year":"2006","unstructured":"Li S, Wang R, Meng Q, Li G, Hu G, Dou W, Li Z, Zhang Z (2006) Intra-ventricular infusion of RAAV1-EGFP Resulted in transduction in multiple regions of adult rat brain: a comparative study with RAAV2 and RAAV5 Vectors. Brain Res 1122:1\u20139","journal-title":"Brain Res"},{"key":"2555_CR60","doi-asserted-by":"crossref","unstructured":"Davidsson M, Wang G, Aldrin-Kirk P, Cardoso T, Nolbrant S, Hartnor M, Parmar M, Bj\u00f6rklund T (2018) Barcoded rational AAV vector evolution enables systematic in vivo mapping of peptide binding motifs. bioRxiv 335372.","DOI":"10.1101\/335372"},{"key":"2555_CR61","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41576-019-0205-4","volume":"21","author":"C Li","year":"2020","unstructured":"Li C, Samulski RJ (2020) Engineering adeno-associated virus vectors for gene therapy. Nat Rev Genet 21:255\u2013272","journal-title":"Nat Rev Genet"},{"key":"2555_CR62","doi-asserted-by":"publisher","first-page":"27053","DOI":"10.1073\/pnas.1910061116","volume":"116","author":"M Davidsson","year":"2019","unstructured":"Davidsson M, Wang G, Aldrin-Kirk P, Cardoso T, Nolbrant S, Hartnor M, Mudannayake J, Parmar M, et al (2019) A systematic capsid evolution approach performed in vivo for the design of AAV vectors with tailored properties and tropism. Proc Natl Acad Sci 116:27053\u201327062","journal-title":"Proc Natl Acad Sci"},{"key":"2555_CR63","doi-asserted-by":"publisher","first-page":"e00391","DOI":"10.1128\/JVI.00391-17","volume":"91","author":"S Pillay","year":"2017","unstructured":"Pillay S, Zou W, Cheng F, Puschnik AS, Meyer NL, Ganaie SS, Deng X, Wosen JE, et al (2017) Adeno-associated virus (AAV) serotypes have distinctive interactions with domains of the cellular AAV receptor. J Virol 91:e00391-17","journal-title":"J Virol"},{"key":"2555_CR64","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ymthe.2006.05.009","volume":"14","author":"Z Wu","year":"2006","unstructured":"Wu Z, Asokan A, Samulski RJ (2006) Adeno-associated virus serotypes: vector toolkit for human gene therapy. Mol Ther 14:316\u2013327. https:\/\/doi.org\/10.1016\/j.ymthe.2006.05.009","journal-title":"Mol Ther"},{"key":"2555_CR65","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/gt.2012.27","volume":"20","author":"EA Salegio","year":"2013","unstructured":"Salegio EA, Samaranch L, Kells AP, Mittermeyer G, San Sebastian W, Zhou S, Beyer J, Forsayeth J, et al (2013) Axonal transport of adeno-associated viral vectors is serotype-dependent. Gene Ther 20:348\u2013352","journal-title":"Gene Ther"},{"key":"2555_CR66","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1212\/01.wnl.0000312381.29287.ff","volume":"70","author":"JL Eberling","year":"2008","unstructured":"Eberling JL, Jagust WJ, Christine CW, Starr P, Larson P, Bankiewicz KS, Aminoff MJ (2008) Results from a Phase I Safety Trial of HAADC Gene Therapy for Parkinson Disease. Neurology 70:1980\u20131983","journal-title":"Neurology"},{"key":"2555_CR67","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S1474-4422(08)70065-6","volume":"7","author":"WJ Marks Jr","year":"2008","unstructured":"Marks WJ Jr, Ostrem JL, Verhagen L, Starr PA, Larson PS, Bakay RA, Taylor R, Cahn-Weiner DA, et al (2008) Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2\u2013neurturin) to patients with idiopathic Parkinson\u2019s disease: an open-label, phase I trial. Lancet Neurol 7:400\u2013408","journal-title":"Lancet Neurol"},{"key":"2555_CR68","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1212\/WNL.0b013e3181c29356","volume":"73","author":"CW Christine","year":"2009","unstructured":"Christine CW, Starr PA, Larson PS, Eberling JL, Jagust WJ, Hawkins RA, VanBrocklin HF, Wright JF, et al (2009) Safety and tolerability of putaminal AADC gene therapy for Parkinson disease. Neurology 73:1662\u20131669","journal-title":"Neurology"},{"key":"2555_CR69","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1038\/mt.2010.135","volume":"18","author":"S Muramatsu","year":"2010","unstructured":"Muramatsu S, Fujimoto K, Kato S, Mizukami H, Asari S, Ikeguchi K, Kawakami T, Urabe M, et al (2010) A phase I study of aromatic L-amino acid decarboxylase gene therapy for Parkinson\u2019s disease. Mol Ther J Am Soc Gene Ther 18:1731\u20131735. https:\/\/doi.org\/10.1038\/mt.2010.135","journal-title":"Mol Ther J Am Soc Gene Ther"},{"key":"2555_CR70","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1001\/jamaneurol.2018.0233","volume":"75","author":"MS Rafii","year":"2018","unstructured":"Rafii MS, Tuszynski MH, Thomas RG, Barba D, Brewer JB, Rissman RA, Siffert J, Aisen PS, et al (2018) Adeno-associated viral vector (serotype 2)-nerve growth factor for patients with Alzheimer disease: a randomized clinical trial. JAMA Neurol. 75:834\u2013841. https:\/\/doi.org\/10.1001\/jamaneurol.2018.0233","journal-title":"JAMA Neurol."},{"key":"2555_CR71","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/S1474-4422(10)70254-4","volume":"9","author":"WJ Marks Jr","year":"2010","unstructured":"Marks WJ Jr, Bartus RT, Siffert J, Davis CS, Lozano A, Boulis N, Vitek J, Stacy M, et al (2010) Gene delivery of AAV2-neurturin for Parkinson\u2019s disease: a double-blind, randomised, controlled trial. Lancet Neurol 9:1164\u20131172. https:\/\/doi.org\/10.1016\/S1474-4422(10)70254-4","journal-title":"Lancet Neurol"},{"key":"2555_CR72","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/s1474-4422(11)70039-4","volume":"10","author":"PA LeWitt","year":"2011","unstructured":"LeWitt PA, Rezai AR, Leehey MA, Ojemann SG, Flaherty AW, Eskandar EN, Kostyk SK, Thomas K, et al (2011) AAV2-GAD Gene therapy for advanced Parkinson\u2019s disease: a double-blind, sham-surgery controlled, randomised trial. Lancet Neurol 10:309\u2013319. https:\/\/doi.org\/10.1016\/s1474-4422(11)70039-4","journal-title":"Lancet Neurol"},{"key":"2555_CR73","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1073\/pnas.0810682106","volume":"106","author":"AP Kells","year":"2009","unstructured":"Kells AP, Hadaczek P, Yin D, Bringas J, Varenika V, Forsayeth J, Bankiewicz KS (2009) Efficient gene therapy-based method for the delivery of therapeutics to primate cortex. Proc Natl Acad Sci 106:2407\u20132411","journal-title":"Proc Natl Acad Sci"},{"key":"2555_CR74","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-60761-533-0_1","volume":"47","author":"J-L Dreyer","year":"2010","unstructured":"Dreyer J-L (2010) Lentiviral vector-mediated gene transfer and rna silencing technology in neuronal dysfunctions. Lentivirus Gene Eng Protoc. 47:3\u201335","journal-title":"Lentivirus Gene Eng Protoc."},{"key":"2555_CR75","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/S0140-6736(13)61939-X","volume":"383","author":"S Palfi","year":"2014","unstructured":"Palfi S, Gurruchaga JM, Ralph GS, Lepetit H, Lavisse S, Buttery PC, Watts C, Miskin J, et al (2014) Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson\u2019s disease: a dose escalation, open-label, phase 1\/2 trial. The Lancet 383:1138\u20131146","journal-title":"The Lancet"},{"key":"2555_CR76","doi-asserted-by":"publisher","first-page":"517","DOI":"10.4155\/tde.10.50","volume":"1","author":"SJ Gray","year":"2010","unstructured":"Gray SJ, Woodard KT, Samulski RJ (2010) Viral vectors and delivery strategies for CNS gene therapy. Ther Deliv 1:517\u2013534","journal-title":"Ther Deliv"},{"key":"2555_CR77","doi-asserted-by":"publisher","first-page":"100977","DOI":"10.1016\/j.arr.2019.100977","volume":"56","author":"A Vaiserman","year":"2019","unstructured":"Vaiserman A, De Falco E, Koliada A, Maslova O, Balistreri CR (2019) Anti-ageing gene therapy: not so far away? Ageing Res Rev 56:100977. https:\/\/doi.org\/10.1016\/j.arr.2019.100977","journal-title":"Ageing Res Rev"},{"key":"2555_CR78","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0163-7258(98)00020-5","volume":"80","author":"PD Robbins","year":"1998","unstructured":"Robbins PD, Ghivizzani SC (1998) Viral vectors for gene therapy. Pharmacol Ther 80:35\u201347","journal-title":"Pharmacol Ther"},{"key":"2555_CR79","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0167-7799(02)00042-2","volume":"21","author":"K Lundstrom","year":"2003","unstructured":"Lundstrom K (2003) Latest development in viral vectors for gene therapy. Trends Biotechnol 21:117\u2013122","journal-title":"Trends Biotechnol"},{"key":"2555_CR80","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/diseases6020042","volume":"6","author":"K Lundstrom","year":"2018","unstructured":"Lundstrom K (2018) Viral Vectors in Gene Therapy. Diseases 6:42","journal-title":"Diseases"},{"key":"2555_CR81","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/BF03256872","volume":"25","author":"K Kamimura","year":"2011","unstructured":"Kamimura K, Suda T, Zhang G, Liu D (2011) Advances in gene delivery systems. Pharm Med 25:293\u2013306","journal-title":"Pharm Med"},{"key":"2555_CR82","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.apsb.2020.01.015","volume":"10","author":"W Chen","year":"2020","unstructured":"Chen W, Hu Y, Ju D (2020) Gene therapy for neurodegenerative disorders: advances, insights and prospects. Acta Pharm Sin B 10:1347\u20131359","journal-title":"Acta Pharm Sin B"},{"key":"2555_CR83","first-page":"GE01","volume":"9","author":"M Ramamoorth","year":"2015","unstructured":"Ramamoorth M, Narvekar A (2015) Non viral vectors in gene therapy-an overview. J. Clin. Diagn. Res 9:GE01","journal-title":"J. Clin. Diagn. Res"},{"key":"2555_CR84","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1208\/s12248-009-9143-y","volume":"11","author":"MS Al-Dosari","year":"2009","unstructured":"Al-Dosari MS, Gao X (2009) Nonviral gene delivery: principle, limitations, and recent progress. AAPS J 11:671\u2013681","journal-title":"AAPS J"},{"key":"2555_CR85","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1038\/sj.gt.3301923","volume":"9","author":"T Niidome","year":"2002","unstructured":"Niidome T, Huang L (2002) Gene therapy progress and prospects: nonviral vectors. Gene Ther 9:1647\u20131652","journal-title":"Gene Ther"},{"key":"2555_CR86","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/B978-0-12-384964-9.00003-7","volume-title":"Challenges in delivery of therapeutic genomics and proteomics","author":"KA Jinturkar","year":"2011","unstructured":"Jinturkar KA, Rathi MN, Misra A (2011) Gene delivery using physical methods. Challenges in delivery of therapeutic genomics and proteomics. Elsevier, Amsterdam, pp 83\u2013126"},{"key":"2555_CR87","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1073\/pnas.91.6.2076","volume":"91","author":"RH Bobo","year":"1994","unstructured":"Bobo RH, Laske DW, Akbasak A, Morrison PF, Dedrick RL, Oldfield EH (1994) Convection-Enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci 91:2076\u20132080","journal-title":"Proc Natl Acad Sci"},{"key":"2555_CR88","doi-asserted-by":"publisher","first-page":"874","DOI":"10.3171\/JNS\/2008\/109\/11\/0874","volume":"109","author":"V Varenika","year":"2008","unstructured":"Varenika V, Dickinson P, Bringas J, LeCouteur R, Higgins R, Park J, Fiandaca M, Berger M, et al (2008) Detection of infusate leakage in the brain using real-time imaging of convection-enhanced delivery. J Neurosurg 109:874\u2013880","journal-title":"J Neurosurg"},{"key":"2555_CR89","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0079-6123(09)17511-8","volume":"175","author":"V Varenika","year":"2009","unstructured":"Varenika V, Kells AP, Valles F, Hadaczek P, Forsayeth J, Bankiewicz KS (2009) Controlled dissemination of aav vectors in the primate brain. Prog Brain Res 175:163\u2013172","journal-title":"Prog Brain Res"},{"key":"2555_CR90","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1227\/01.NEU.0000350229.77462.2F","volume":"65","author":"F Valles","year":"2009","unstructured":"Valles F, Fiandaca MS, Bringas J, Dickinson P, LeCouteur R, Higgins R, Berger M, Forsayeth J et al (2009) Anatomic compression caused by high-volume convection-enhanced delivery to the brain. Neurosurgery 65:579\u2013586","journal-title":"Neurosurgery"},{"key":"2555_CR91","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1227\/NEU.0b013e3181f53a5c","volume":"67","author":"F Valles","year":"2010","unstructured":"Valles F, Fiandaca MS, Eberling JL, Starr PA, Larson PS, Christine CW, Forsayeth J, Richardson RM, Su X, Aminoff MJ (2010) Qualitative Imaging of adeno-associated virus serotype 2\u2013human aromatic L-amino acid decarboxylase gene therapy in a phase I study for the treatment of Parkinson disease. Neurosurgery 67:1377\u20131385","journal-title":"Neurosurgery"},{"key":"2555_CR92","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3171\/2010.2.JNS091744","volume":"113","author":"D Yin","year":"2010","unstructured":"Yin D, Richardson RM, Fiandaca MS, Bringas J, Forsayeth J, Berger MS, Bankiewicz KS (2010) Cannula placement for effective convection-enhanced delivery in the nonhuman primate thalamus and brainstem: implications for clinical delivery of therapeutics. J Neurosurg 113:240\u2013248","journal-title":"J Neurosurg"},{"key":"2555_CR93","doi-asserted-by":"publisher","first-page":"S196","DOI":"10.1016\/j.neuroimage.2009.08.069","volume":"54","author":"D Yin","year":"2011","unstructured":"Yin D, Valles FE, Fiandaca MS, Bringas J, Gimenez F, Berger MS, Forsayeth J, Bankiewicz KS (2011) Optimal region of the putamen for image-guided convection-enhanced delivery of therapeutics in human and non-human primates. Neuroimage 54:S196\u2013S203","journal-title":"Neuroimage"},{"key":"2555_CR94","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1159\/000323544","volume":"89","author":"RM Richardson","year":"2011","unstructured":"Richardson RM, Kells AP, Martin AJ, Larson PS, Starr PA, Piferi PG, Bates G, Tansey L, Rosenbluth KH, Bringas JR (2011) Novel platform for mri-guided convection-enhanced delivery of therapeutics: preclinical validation in nonhuman primate brain. Stereotact Funct Neurosurg 89:141\u2013151","journal-title":"Stereotact Funct Neurosurg"},{"key":"2555_CR95","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1038\/mt.2010.114","volume":"18","author":"X Su","year":"2010","unstructured":"Su X, Kells AP, Salegio EA, Richardson RM, Hadaczek P, Beyer J, Bringas J, Pivirotto P, Forsayeth J, Bankiewicz KS (2010) Real-time MR imaging with gadoteridol predicts distribution of transgenes after convection-enhanced delivery of AAV2 vectors. Mol Ther 18:1490\u20131495","journal-title":"Mol Ther"},{"key":"2555_CR96","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1038\/mt.2011.11","volume":"19","author":"RM Richardson","year":"2011","unstructured":"Richardson RM, Kells AP, Rosenbluth KH, Salegio EA, Fiandaca MS, Larson PS, Starr PA, Martin AJ, Lonser RR, Federoff HJ (2011) Interventional MRI-guided putaminal delivery of AAV2-GDNF for a Planned clinical trial in Parkinson\u2019s disease. Mol Ther 19:1048\u20131057","journal-title":"Mol Ther"},{"key":"2555_CR97","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/bfgp\/elm005","volume":"6","author":"A Jagannath","year":"2007","unstructured":"Jagannath A, Wood M (2007) RNA interference based gene therapy for neurological disease. Brief Funct Genomic Proteomic 6:40\u201349","journal-title":"Brief Funct Genomic Proteomic"},{"key":"2555_CR98","doi-asserted-by":"publisher","first-page":"51","DOI":"10.18609\/cgti.2019.007","volume":"5","author":"A Nyamay\u2019Antu","year":"2019","unstructured":"Nyamay\u2019Antu A, Dumont M, Kedinger V, Erbacher P (2019) Non-viral vector mediated gene delivery: the outsider to watch out for in gene therapy. Cell Gene Ther Insights 5:51\u201357","journal-title":"Cell Gene Ther Insights"},{"key":"2555_CR99","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10565-009-9141-y","volume":"26","author":"SL Hart","year":"2010","unstructured":"Hart SL (2010) Multifunctional nanocomplexes for gene transfer and gene therapy. Cell Biol Toxicol 26:69\u201381","journal-title":"Cell Biol Toxicol"},{"key":"2555_CR100","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0924-4204(00)80002-5","volume":"10","author":"\u00c9 Vivien","year":"1999","unstructured":"Vivien \u00c9, Oudrhiri N, Vigneron J-P, Hauchecorne M, Ramasawmy R, Riquier S, Toury R, Fabrega S, Navarro J, Lehn J-M et al (1999) Vecteurs Synth\u00e9tiques Pour Le Transfert de G\u00e8nes: \u00c9tat Actuel et Perspectives. Ann Inst Pasteur Actual 10:301\u2013312. https:\/\/doi.org\/10.1016\/S0924-4204(00)80002-5","journal-title":"Ann Inst Pasteur Actual"},{"key":"2555_CR101","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1128\/jvi.74.1.505-512.2000","volume":"74","author":"EJ Kremer","year":"2000","unstructured":"Kremer EJ, Boutin S, Chillon M, Danos O (2000) Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer. J Virol 74:505\u2013512. https:\/\/doi.org\/10.1128\/jvi.74.1.505-512.2000","journal-title":"J Virol"},{"key":"2555_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7860\/JCDR\/2015\/10443.5394","volume":"9","author":"M Ramamoorth","year":"2015","unstructured":"Ramamoorth M, Narvekar A (2015) Non viral vectors in gene therapy- an overview. J Clin Diagn Res 9:1\u20136. https:\/\/doi.org\/10.7860\/JCDR\/2015\/10443.5394","journal-title":"J Clin Diagn Res"},{"key":"2555_CR103","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.ymthe.2003.09.011","volume":"8","author":"D Pinto-Gonz\u00e1lez Howell","year":"2003","unstructured":"Pinto-Gonz\u00e1lez Howell D, Krieser RJ, Eastman A, Barry MA (2003) Deoxyribonuclease II is a lysosomal barrier to transfection. Mol Ther 8:957\u2013963. https:\/\/doi.org\/10.1016\/j.ymthe.2003.09.011","journal-title":"Mol Ther"},{"key":"2555_CR104","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/jgm.1338","volume":"11","author":"Y Matsumoto","year":"2009","unstructured":"Matsumoto Y, Itaka K, Yamasoba T, Kataoka K (2009) Intranuclear fluorescence resonance energy transfer analysis of plasmid DNA decondensation from nonviral gene carriers. J Gene Med 11:615\u2013623. https:\/\/doi.org\/10.1002\/jgm.1338","journal-title":"J Gene Med"},{"key":"2555_CR105","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/sj.gt.3302838","volume":"13","author":"S-D Li","year":"2006","unstructured":"Li S-D, Huang L (2006) Gene therapy progress and prospects: non-viral gene therapy by systemic delivery. Gene Ther 13:1313\u20131319. https:\/\/doi.org\/10.1038\/sj.gt.3302838","journal-title":"Gene Ther"},{"key":"2555_CR106","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1016\/j.addr.2005.09.017","volume":"57","author":"C Duf\u00e8s","year":"2005","unstructured":"Duf\u00e8s C, Uchegbu IF, Sch\u00e4tzlein AG (2005) Dendrimers in gene delivery. Adv Drug Deliv Rev 57:2177\u20132202. https:\/\/doi.org\/10.1016\/j.addr.2005.09.017","journal-title":"Adv Drug Deliv Rev"},{"key":"2555_CR107","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1096\/fj.06-7380com","volume":"21","author":"R-Q Huang","year":"2007","unstructured":"Huang R-Q, Qu Y-H, Ke W-L, Zhu J-H, Pei Y-Y, Jiang C (2007) Efficient gene delivery targeted to the brain using a transferrin-conjugated polyethyleneglycol-modified polyamidoamine dendrimer. FASEB J 21:1117\u20131125. https:\/\/doi.org\/10.1096\/fj.06-7380com","journal-title":"FASEB J"},{"key":"2555_CR108","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1021\/bc060327a","volume":"18","author":"V Knorr","year":"2007","unstructured":"Knorr V, Allmendinger L, Walker GF, Paintner FF, Wagner E (2007) An acetal-based PEGylation reagent for PH-sensitive shielding of DNA polyplexes. Bioconjug Chem 18:1218\u20131225. https:\/\/doi.org\/10.1021\/bc060327a","journal-title":"Bioconjug Chem"},{"key":"2555_CR109","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/sj.mt.6300326","volume":"16","author":"JA Wolff","year":"2008","unstructured":"Wolff JA, Rozema DB (2008) Breaking the bonds: non-viral vectors become chemically dynamic. Mol Ther 16:8\u201315. https:\/\/doi.org\/10.1038\/sj.mt.6300326","journal-title":"Mol Ther"},{"key":"2555_CR110","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jconrel.2008.05.023","volume":"130","author":"M Piest","year":"2008","unstructured":"Piest M, Lin C, Mateos-Timoneda MA, Lok MC, Hennink WE, Feijen J, Engbersen JFJ (2008) Novel Poly(Amido Amine)s with Bioreducible Disulfide Linkages in Their Diamino-Units: Structure Effects and in Vitro Gene Transfer Properties. J Controlled Release 130:38\u201345. https:\/\/doi.org\/10.1016\/j.jconrel.2008.05.023","journal-title":"J Controlled Release"},{"key":"2555_CR111","volume-title":"Microbiology: An Evolving Science Fifth International Student Edition with Ebook, Smartwork5, Animations ETopics and EAppendices","author":"JL Slonczewski","year":"2020","unstructured":"Slonczewski JL, Foster JW, Foster E (2020) Microbiology: An Evolving Science Fifth International Student Edition with Ebook, Smartwork5, Animations ETopics and EAppendices. WW Norton & Company, New York"},{"key":"2555_CR112","volume-title":"Fundamentals of Biochemistry: Life at the Molecular Level","author":"D Voet","year":"2016","unstructured":"Voet D, Voet JG, Pratt CW (2016) Fundamentals of Biochemistry: Life at the Molecular Level. John Wiley & Sons, Hoboken"},{"key":"2555_CR113","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/978-1-60327-248-3_13","volume-title":"Gene Therapy Protocols","author":"C Zheng","year":"2008","unstructured":"Zheng C, Baum BJ (2008) Evaluation of promoters for use in tissue-specific gene delivery. Gene Therapy Protocols. Springer, pp 205\u2013219"},{"key":"2555_CR114","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1074\/jbc.M310471200","volume":"279","author":"GM Skinner","year":"2004","unstructured":"Skinner GM, Baumann CG, Quinn DM, Molloy JE, Hoggett JG (2004) Promoter Binding, initiation, and elongation by bacteriophage T7 RNA polymerase: a single-molecule view of the transcription cycle. J Biol Chem 279:3239\u20133244","journal-title":"J Biol Chem"},{"key":"2555_CR115","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1038\/sj.gt.3300989","volume":"6","author":"TC Wyman","year":"1999","unstructured":"Wyman TC, Rohrer DC, Kirigiti P, Nichols HV, Pilcher KY, Nilaver G, Machida CA (1999) Promoter-activated expression of nerve growth factor for treatment of neurodegenerative diseases. Gene Ther 6:1648\u20131660","journal-title":"Gene Ther"},{"key":"2555_CR116","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1567-1364.2011.00769.x","volume":"12","author":"NA Da Silva","year":"2012","unstructured":"Da Silva NA, Srikrishnan S (2012) Introduction and expression of genes for metabolic engineering applications in Saccharomyces cerevisiae. FEMS Yeast Res 12:197\u2013214","journal-title":"FEMS Yeast Res"},{"key":"2555_CR117","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1534\/genetics.110.119917","volume":"186","author":"BD Pfeiffer","year":"2010","unstructured":"Pfeiffer BD, Ngo T-TB, Hibbard KL, Murphy C, Jenett A, Truman JW, Rubin GM (2010) Refinement of tools for targeted gene expression in Drosophila. Genetics 186:735\u2013755","journal-title":"Genetics"},{"key":"2555_CR118","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1128\/jb.174.10.3377-3385.1992","volume":"174","author":"LK Lewis","year":"1992","unstructured":"Lewis LK, Jenkins ME, Mount DW (1992) Isolation of DNA damage-inducible promoters in Escherichia coli: regulation of PolB (DinA), DinG, and DinH by LexA Repressor. J Bacteriol 174:3377\u20133385","journal-title":"J Bacteriol"},{"key":"2555_CR119","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/978-1-60761-765-5_5","volume-title":"Plant Developmental Biology","author":"L Borghi","year":"2010","unstructured":"Borghi L (2010) Inducible gene expression systems for plants. Plant Developmental Biology. Springer, Berlin, pp 65\u201375"},{"key":"2555_CR120","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1021\/sb500273n","volume":"3","author":"SR Schmidl","year":"2014","unstructured":"Schmidl SR, Sheth RU, Wu A, Tabor JJ (2014) Refactoring and optimization of light-switchable Escherichia coli two-component systems. ACS Synth Biol 3:820\u2013831","journal-title":"ACS Synth Biol"},{"key":"2555_CR121","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jmb.2010.10.038","volume":"405","author":"JJ Tabor","year":"2011","unstructured":"Tabor JJ, Levskaya A, Voigt CA (2011) Multichromatic control of gene expression in Escherichia coli. J Mol Biol 405:315\u2013324","journal-title":"J Mol Biol"},{"key":"2555_CR122","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/gt.2010.138","volume":"18","author":"MG Toscano","year":"2011","unstructured":"Toscano MG, Romero Z, Munoz P, Cobo M, Benabdellah K, Martin F (2011) Physiological and tissue-specific vectors for treatment of inherited diseases. Gene Ther 18:117\u2013127","journal-title":"Gene Ther"},{"key":"2555_CR123","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.tplants.2007.01.002","volume":"12","author":"M Venter","year":"2007","unstructured":"Venter M (2007) Synthetic promoters: genetic control through Cis engineering. Trends Plant Sci 12:118\u2013124","journal-title":"Trends Plant Sci"},{"key":"2555_CR124","doi-asserted-by":"publisher","first-page":"6357","DOI":"10.1007\/s00253-018-9115-1","volume":"102","author":"J Kluge","year":"2018","unstructured":"Kluge J, Terfehr D, K\u00fcck U (2018) Inducible promoters and functional genomic approaches for the genetic engineering of filamentous fungi. Appl Microbiol Biotechnol 102:6357\u20136372","journal-title":"Appl Microbiol Biotechnol"},{"key":"2555_CR125","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1523\/JNEUROSCI.14-03-01030.1994","volume":"14","author":"M Brenner","year":"1994","unstructured":"Brenner M, Kisseberth WC, Su Y, Besnard F, Messing A (1994) GFAP Promoter Directs astrocyte-specific expression in transgenic mice. J Neurosci Off J Soc Neurosci 14:1030\u20131037. https:\/\/doi.org\/10.1523\/JNEUROSCI.14-03-01030.1994","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"2555_CR126","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0166-2236(96)89620-2","volume":"19","author":"G Karpati","year":"1996","unstructured":"Karpati G, Lochm\u00fcller H, Nalbantoglu J, Durham H (1996) The principles of gene therapy for the nervous system. Trends Neurosci 19:49\u201354. https:\/\/doi.org\/10.1016\/0166-2236(96)89620-2","journal-title":"Trends Neurosci"},{"key":"2555_CR127","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1002\/j.1460-2075.1988.tb03136.x","volume":"7","author":"JM Salbaum","year":"1988","unstructured":"Salbaum JM, Weidemann A, Lemaire HG, Masters CL, Beyreuther K (1988) The promoter of Alzheimer\u2019s disease amyloid A4 precursor gene. EMBO J 7:2807\u20132813","journal-title":"EMBO J"},{"key":"2555_CR128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1096\/fj.04-2637fje","volume":"19","author":"Y Ohyagi","year":"2005","unstructured":"Ohyagi Y, Asahara H, Chui D-H, Tsuruta Y, Sakae N, Miyoshi K, Yamada T, Kikuchi H, Taniwaki T, Murai H (2005) Intracellular A\u03b242 activates P53 promoter: a pathway to neurodegeneration in Alzheimer\u2019s disease. FASEB J 19:1\u201329","journal-title":"FASEB J"},{"key":"2555_CR129","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/ejhg.2008.263","volume":"17","author":"A Bizzarro","year":"2009","unstructured":"Bizzarro A, Seripa D, Acciarri A, Matera MG, Pilotto A, Tiziano FD, Brahe C, Masullo C (2009) The complex interaction between APOE promoter and AD: an Italian case\u2013control study. Eur J Hum Genet 17:938\u2013945","journal-title":"Eur J Hum Genet"},{"key":"2555_CR130","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1001\/archneur.61.9.1434","volume":"61","author":"B Tycko","year":"2004","unstructured":"Tycko B, Lee JH, Ciappa A, Saxena A, Li C-M, Feng L, Arriaga A, Stern Y, Lantigua R, Shachter N (2004) APOE and APOC1 promoter polymorphisms and the risk of Alzheimer disease in African American and Caribbean Hispanic Individuals. Arch Neurol 61:1434\u20131439","journal-title":"Arch Neurol"},{"key":"2555_CR131","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.neurobiolaging.2005.11.009","volume":"28","author":"L Segat","year":"2007","unstructured":"Segat L, Pontillo A, Annoni G, Trabattoni D, Vergani C, Clerici M, Arosio B, Crovella S (2007) PIN1 Promoter polymorphisms are associated with Alzheimer\u2019s disease. Neurobiol Aging 28:69\u201374","journal-title":"Neurobiol Aging"},{"key":"2555_CR132","doi-asserted-by":"publisher","first-page":"107870","DOI":"10.18632\/oncotarget.22330","volume":"8","author":"W Ji","year":"2017","unstructured":"Ji W, Zhang Y (2017) The association of MPO gene promoter polymorphisms with Alzheimer\u2019s disease risk in Chinese Han Population. Oncotarget 8:107870","journal-title":"Oncotarget"},{"key":"2555_CR133","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neulet.2012.09.059","volume":"530","author":"EE Wettergren","year":"2012","unstructured":"Wettergren EE, Gussing F, Quintino L, Lundberg C (2012) Novel disease-specific promoters for use in gene therapy for Parkinson\u2019s disease. Neurosci Lett 530:29\u201334","journal-title":"Neurosci Lett"},{"key":"2555_CR134","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/jnc.13261","volume":"135","author":"M Ay","year":"2015","unstructured":"Ay M, Jin H, Harischandra DS, Asaithambi A, Kanthasamy A, Anantharam V, Kanthasamy AG (2015) Molecular cloning, epigenetic regulation, and functional characterization of Prkd1 gene promoter in dopaminergic cell culture models of Parkinson\u2019s disease. J Neurochem 135:402\u2013415","journal-title":"J Neurochem"},{"key":"2555_CR135","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/sj.gt.3302377","volume":"11","author":"D Suwelack","year":"2004","unstructured":"Suwelack D, Hurtado-Lorenzo A, Millan E, Gonzalez-Nicolini V, Wawrowsky K, Lowenstein PR, Castro MG (2004) Neuronal Expression of the Transcription Factor Gli1 Using the T\u03b11 \u03b1-Tubulin Promoter Is Neuroprotective in an Experimental Model of Parkinson\u2019s Disease. Gene Ther 11:1742\u20131752","journal-title":"Gene Ther"},{"key":"2555_CR136","doi-asserted-by":"publisher","first-page":"7084","DOI":"10.1096\/fj.201802752R","volume":"33","author":"BA Harlan","year":"2019","unstructured":"Harlan BA, Pehar M, Killoy KM, Vargas MR (2019) Enhanced SIRT6 Activity Abrogates the Neurotoxic Phenotype of Astrocytes Expressing ALS-Linked Mutant SOD1. FASEB J 33:7084\u20137091","journal-title":"FASEB J"},{"key":"2555_CR137","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1097\/00001756-199512150-00009","volume":"6","author":"F Finiels","year":"1995","unstructured":"Finiels F, y Ribotta MG, Barkats M, Samolyk M-L, Robert JJ, Privat A, Revah F, Mallet J (1995) Specific and Efficient Genetransfer Strategy Offers New Potentialities for the Treatment of Motor Neurone Diseases. Neuroreport 6:2473\u20132478","journal-title":"Neuroreport"},{"issue":"2","key":"2555_CR138","first-page":"132","volume":"2","author":"G Ghadge","year":"1995","unstructured":"Ghadge G, Roos R, Kang U, Wollmann R, Fishman P, Kalynych A, Barr E, Leiden J (1995) CNS Gene Delivery by Retrograde Transport of Recombinant Replication-Defective Adenoviruses. Gene Ther 2(2):132\u2013137","journal-title":"Gene Ther"},{"key":"2555_CR139","first-page":"23","volume":"122","author":"F Mingozzi","year":"2013","unstructured":"Mingozzi F, High KA (2013) Immune Responses to AAV Vectors: Overcoming Barriers to Successful Gene Therapy. Blood J Am Soc Hematol 122:23\u201336","journal-title":"Blood J Am Soc Hematol"},{"key":"2555_CR140","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/ng1179","volume":"34","author":"H Nakai","year":"2003","unstructured":"Nakai H, Montini E, Fuess S, Storm TA, Grompe M, Kay MA (2003) AAV Serotype 2 Vectors Preferentially Integrate into Active Genes in Mice. Nat Genet 34:297\u2013302","journal-title":"Nat Genet"},{"key":"2555_CR141","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1089\/hum.2017.009","volume":"28","author":"RJ Chandler","year":"2017","unstructured":"Chandler RJ, Sands MS, Venditti CP (2017) Recombinant Adeno-Associated Viral Integration and Genotoxicity: Insights from Animal Models. Hum Gene Ther 28:314\u2013322","journal-title":"Hum Gene Ther"},{"key":"2555_CR142","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/ng.3389","volume":"47","author":"J-C Nault","year":"2015","unstructured":"Nault J-C, Datta S, Imbeaud S, Franconi A, Mallet M, Couchy G, Letouz\u00e9 E, Pilati C, Verret B, Blanc J-F (2015) Recurrent AAV2-Related Insertional Mutagenesis in Human Hepatocellular Carcinomas. Nat Genet 47:1187\u20131193","journal-title":"Nat Genet"},{"key":"2555_CR143","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s40265-014-0339-9","volume":"75","author":"LJ Scott","year":"2015","unstructured":"Scott LJ (2015) Alipogene Tiparvovec: A Review of Its Use in Adults with Familial Lipoprotein Lipase Deficiency. Drugs 75:175\u2013182","journal-title":"Drugs"},{"key":"2555_CR144","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1586\/17512433.2014.852065","volume":"7","author":"F Salmon","year":"2014","unstructured":"Salmon F, Grosios K, Petry H (2014) Safety Profile of Recombinant Adeno-Associated Viral Vectors: Focus on Alipogene Tiparvovec (Glybera\u00ae). Expert Rev Clin Pharmacol 7:53\u201365","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2555_CR145","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1517\/17425247.2014.871258","volume":"11","author":"D Wang","year":"2014","unstructured":"Wang D, Zhong L, Nahid MA, Gao G (2014) The Potential of Adeno-Associated Viral Vectors for Gene Delivery to Muscle Tissue. Expert Opin Drug Deliv 11:345\u2013364","journal-title":"Expert Opin Drug Deliv"},{"key":"2555_CR146","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1089\/hum.2016.087","volume":"27","author":"M Hocquemiller","year":"2016","unstructured":"Hocquemiller M, Giersch L, Audrain M, Parker S, Cartier N (2016) Adeno-Associated Virus-Based Gene Therapy for CNS Diseases. Hum Gene Ther 27:478\u2013496","journal-title":"Hum Gene Ther"},{"key":"2555_CR147","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1177\/1073858414521870","volume":"21","author":"DS Ojala","year":"2015","unstructured":"Ojala DS, Amara DP, Schaffer DV (2015) Adeno-Associated Virus Vectors and Neurological Gene Therapy. Neuroscientist 21:84\u201398","journal-title":"Neuroscientist"},{"key":"2555_CR148","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/mt.2014.68","volume":"22","author":"B Yang","year":"2014","unstructured":"Yang B, Li S, Wang H, Guo Y, Gessler DJ, Cao C, Su Q, Kramer J, Zhong L, Ahmed SS (2014) Global CNS Transduction of Adult Mice by Intravenously Delivered RAAVrh. 8 and RAAVrh. 10 and Nonhuman Primates by RAAVrh. 10. Mol. Ther. 22:1299\u20131309","journal-title":"Mol. Ther."},{"key":"2555_CR149","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/gt.2012.101","volume":"20","author":"SJ Gray","year":"2013","unstructured":"Gray SJ, Kalburgi SN, McCown TJ, Samulski RJ (2013) Global CNS Gene Delivery and Evasion of Anti-AAV-Neutralizing Antibodies by Intrathecal AAV Administration in Non-Human Primates. Gene Ther 20:450\u2013459","journal-title":"Gene Ther"},{"key":"2555_CR150","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1093\/hmg\/ddt454","volume":"23","author":"H Wang","year":"2014","unstructured":"Wang H, Yang B, Qiu L, Yang C, Kramer J, Su Q, Guo Y, Brown RH Jr, Gao G, Xu Z (2014) Widespread Spinal Cord Transduction by Intrathecal Injection of RAAV Delivers Efficacious RNAi Therapy for Amyotrophic Lateral Sclerosis. Hum Mol Genet 23:668\u2013681","journal-title":"Hum Mol Genet"},{"key":"2555_CR151","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jconrel.2016.09.011","volume":"241","author":"J Saraiva","year":"2016","unstructured":"Saraiva J, Nobre RJ, de Almeida LP (2016) Gene Therapy for the CNS Using AAVs: The Impact of Systemic Delivery by AAV9. J Controlled Release 241:94\u2013109","journal-title":"J Controlled Release"},{"key":"2555_CR152","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J (2016) The Amyloid Hypothesis of Alzheimer\u2019s Disease at 25 Years. EMBO Mol Med 8:595\u2013608","journal-title":"EMBO Mol Med"},{"key":"2555_CR153","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000332218","volume":"79","author":"R Anand","year":"2012","unstructured":"Anand R, Kaushal A, Wani WY, Gill KD (2012) Road to Alzheimer\u2019s Disease: The Pathomechanism Underlying. Pathobiology 79:55\u201371","journal-title":"Pathobiology"},{"key":"2555_CR154","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00401-015-1518-9","volume":"131","author":"I St-Amour","year":"2016","unstructured":"St-Amour I, Cicchetti F, Calon F (2016) Immunotherapies in Alzheimer\u2019s Disease: Too Much, Too Little, Too Late or off-Target? Acta Neuropathol (Berl) 131:481\u2013504","journal-title":"Acta Neuropathol (Berl)"},{"key":"2555_CR155","doi-asserted-by":"publisher","first-page":"e57606","DOI":"10.1371\/journal.pone.0057606","volume":"8","author":"M Shimada","year":"2013","unstructured":"Shimada M, Abe S, Takahashi T, Shiozaki K, Okuda M, Mizukami H, Klinman DM, Ozawa K, Okuda K (2013) Prophylaxis and Treatment of Alzheimer\u2019s Disease by Delivery of an Adeno-Associated Virus Encoding a Monoclonal Antibody Targeting the Amyloid Beta Protein. PloS One 8:e57606","journal-title":"PloS One"},{"key":"2555_CR156","first-page":"285","volume":"19","author":"KM Fish","year":"2015","unstructured":"Fish KM (2015) Advances in Gene Therapy for Heart Failure. Discov Med 19:285\u2013291","journal-title":"Discov Med"},{"key":"2555_CR157","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jjcc.2015.02.006","volume":"66","author":"B Greenberg","year":"2015","unstructured":"Greenberg B (2015) Gene Therapy for Heart Failure. J Cardiol 66:195\u2013200","journal-title":"J Cardiol"},{"key":"2555_CR158","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/S0140-6736(16)00082-9","volume":"387","author":"B Greenberg","year":"2016","unstructured":"Greenberg B, Butler J, Felker GM, Ponikowski P, Voors AA, Desai AS, Barnard D, Bouchard A, Jaski B, Lyon AR (2016) Calcium Upregulation by Percutaneous Administration of Gene Therapy in Patients with Cardiac Disease (CUPID 2): A Randomised, Multinational, Double-Blind, Placebo-Controlled, Phase 2b Trial. The Lancet 387:1178\u20131186","journal-title":"The Lancet"},{"key":"2555_CR159","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jchf.2013.09.008","volume":"2","author":"B Greenberg","year":"2014","unstructured":"Greenberg B, Yaroshinsky A, Zsebo KM, Butler J, Felker GM, Voors AA, Rudy JJ, Wagner K, Hajjar RJ (2014) Design of a Phase 2b Trial of Intracoronary Administration of AAV1\/SERCA2a in Patients with Advanced Heart Failure: The CUPID 2 Trial (Calcium up-Regulation by Percutaneous Administration of Gene Therapy in Cardiac Disease Phase 2b). JACC Heart Fail 2:84\u201392","journal-title":"JACC Heart Fail"},{"key":"2555_CR160","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1089\/hum.2015.027","volume":"26","author":"U Griesenbach","year":"2015","unstructured":"Griesenbach U, Pytel KM, Alton EW (2015) Cystic Fibrosis Gene Therapy in the UK and Elsewhere. Hum Gene Ther 26:266\u2013275","journal-title":"Hum Gene Ther"},{"key":"2555_CR161","first-page":"29","volume":"5","author":"TJ Burney","year":"2012","unstructured":"Burney TJ, Davies JC (2012) Gene Therapy for the Treatment of Cystic Fibrosis. Appl Clin Genet 5:29","journal-title":"Appl Clin Genet"},{"key":"2555_CR162","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/mt.2014.89","volume":"22","author":"BS Schuster","year":"2014","unstructured":"Schuster BS, Kim AJ, Kays JC, Kanzawa MM, Guggino WB, Boyle MP, Rowe SM, Muzyczka N, Suk JS, Hanes J (2014) Overcoming the Cystic Fibrosis Sputum Barrier to Leading Adeno-Associated Virus Gene Therapy Vectors. Mol Ther 22:1484\u20131493","journal-title":"Mol Ther"},{"key":"2555_CR163","doi-asserted-by":"publisher","first-page":"187ra72","DOI":"10.1126\/scitranslmed.3006299","volume":"5","author":"MP Limberis","year":"2013","unstructured":"Limberis MP, Adam VS, Wong G, Gren J, Kobasa D, Ross TM, Kobinger GP, Tretiakova A, Wilson JM (2013) Intranasal Antibody Gene Transfer in Mice and Ferrets Elicits Broad Protection against Pandemic Influenza. Sci. Transl. Med. 5:187ra72","journal-title":"Sci. Transl. Med."},{"key":"2555_CR164","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nbt.1515","volume":"27","author":"KD Foust","year":"2009","unstructured":"Foust KD, Nurre E, Montgomery CL, Hernandez A, Chan CM, Kaspar BK (2009) Intravascular AAV9 Preferentially Targets Neonatal Neurons and Adult Astrocytes. Nat Biotechnol 27:59\u201365. https:\/\/doi.org\/10.1038\/nbt.1515","journal-title":"Nat Biotechnol"},{"key":"2555_CR165","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.neuron.2019.02.017","volume":"101","author":"E Hudry","year":"2019","unstructured":"Hudry E, Vandenberghe LH (2019) Therapeutic AAV Gene Transfer to the Nervous System: A Clinical Reality. Neuron 101:839\u2013862","journal-title":"Neuron"},{"key":"2555_CR166","doi-asserted-by":"publisher","first-page":"15055","DOI":"10.1038\/mtm.2015.55","volume":"3","author":"V Lukashchuk","year":"2016","unstructured":"Lukashchuk V, Lewis KE, Coldicott I, Grierson AJ, Azzouz M (2016) AAV9-Mediated Central Nervous System-Targeted Gene Delivery via Cisterna Magna Route in Mice. Mol Ther - Methods Clin Dev 3:15055. https:\/\/doi.org\/10.1038\/mtm.2015.55","journal-title":"Mol Ther - Methods Clin Dev"},{"key":"2555_CR167","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s11689-018-9234-0","volume":"10","author":"EA Lykken","year":"2018","unstructured":"Lykken EA, Shyng C, Edwards RJ, Rozenberg A, Gray SJ (2018) Recent Progress and Considerations for AAV Gene Therapies Targeting the Central Nervous System. J Neurodev Disord 10:1\u201310","journal-title":"J Neurodev Disord"},{"key":"2555_CR168","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1089\/humc.2018.081","volume":"29","author":"S Palfi","year":"2018","unstructured":"Palfi S, Gurruchaga JM, Lepetit H, Howard K, Ralph GS, Mason S, Gouello G, Domenech P, Buttery PC, Hantraye P (2018) Long-Term Follow-up of a Phase I\/II Study of ProSavin, a Lentiviral Vector Gene Therapy for Parkinson\u2019s Disease. Hum Gene Ther Clin Dev 29:148\u2013155","journal-title":"Hum Gene Ther Clin Dev"},{"key":"2555_CR169","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.metabol.2014.10.034","volume":"64","author":"R Wurtman","year":"2015","unstructured":"Wurtman R (2015) Biomarkers in the Diagnosis and Management of Alzheimer\u2019s Disease. Metab - Clin Exp 64:S47\u2013S50. https:\/\/doi.org\/10.1016\/j.metabol.2014.10.034","journal-title":"Metab - Clin Exp"},{"key":"2555_CR170","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.brainres.2014.10.031","volume":"1607","author":"N Bakkar","year":"2015","unstructured":"Bakkar N, Boehringer A, Bowser R (2015) Use of Biomarkers in ALS Drug Development and Clinical Trials. Brain Res 1607:94\u2013107. https:\/\/doi.org\/10.1016\/j.brainres.2014.10.031","journal-title":"Brain Res"},{"key":"2555_CR171","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.tips.2015.03.002","volume":"36","author":"K Blennow","year":"2015","unstructured":"Blennow K, Mattsson N, Sch\u00f6ll M, Hansson O, Zetterberg H (2015) Amyloid Biomarkers in Alzheimer\u2019s Disease. Trends Pharmacol Sci 36:297\u2013309. https:\/\/doi.org\/10.1016\/j.tips.2015.03.002","journal-title":"Trends Pharmacol Sci"},{"key":"2555_CR172","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1136\/jnnp-2013-307539","volume":"85","author":"N Magdalinou","year":"2014","unstructured":"Magdalinou N, Lees AJ, Zetterberg H (2014) Cerebrospinal Fluid Biomarkers in Parkinsonian Conditions: An Update and Future Directions. J. Neurol. Neurosurg. Ampamp Psychiatry 85:1065\u20131075. https:\/\/doi.org\/10.1136\/jnnp-2013-307539","journal-title":"J. Neurol. Neurosurg. Ampamp Psychiatry"},{"key":"2555_CR173","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.3727\/096368912X638964","volume":"21","author":"HJ Lee","year":"2012","unstructured":"Lee HJ, Lim IJ, Park SW, Kim YB, Ko Y, Kim SU (2012) Human Neural Stem Cells Genetically Modified to Express Human Nerve Growth Factor (NGF) Gene Restore Cognition in the Mouse with Ibotenic Acid-Induced Cognitive Dysfunction. Cell Transplant 21:2487\u20132496","journal-title":"Cell Transplant"},{"key":"2555_CR174","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1159\/000124979","volume":"75","author":"S Wu","year":"2008","unstructured":"Wu S, Sasaki A, Yoshimoto R, Kawahara Y, Manabe T, Kataoka K, Asashima M, Yuge L (2008) Neural Stem Cells Improve Learning and Memory in Rats with Alzheimer\u2019s Disease. Pathobiology 75:186\u2013194","journal-title":"Pathobiology"},{"key":"2555_CR175","doi-asserted-by":"publisher","first-page":"13594","DOI":"10.1073\/pnas.0901402106","volume":"106","author":"M Blurton-Jones","year":"2009","unstructured":"Blurton-Jones M, Kitazawa M, Martinez-Coria H, Castello NA, M\u00fcller F-J, Loring JF, Yamasaki TR, Poon WW, Green KN, LaFerla FM (2009) Neural Stem Cells Improve Cognition via BDNF in a Transgenic Model of Alzheimer Disease. Proc Natl Acad Sci 106:13594\u201313599","journal-title":"Proc Natl Acad Sci"},{"key":"2555_CR176","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.stemcr.2015.09.008","volume":"5","author":"NR Goldberg","year":"2015","unstructured":"Goldberg NR, Caesar J, Park A, Sedgh S, Finogenov G, Masliah E, Davis J, Blurton-Jones M (2015) Neural Stem Cells Rescue Cognitive and Motor Dysfunction in a Transgenic Model of Dementia with Lewy Bodies through a BDNF-Dependent Mechanism. Stem Cell Rep 5:791\u2013804","journal-title":"Stem Cell Rep"},{"key":"2555_CR177","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/0006-291X(90)91201-3","volume":"171","author":"EG Stopa","year":"1990","unstructured":"Stopa EG, Gonzalez A-M, Chorsky R, Corona RJ, Alvarez J, Bird ED, Baird A (1990) Basic Fibroblast Growth Factor in Alzheimer\u2019s Disease. Biochem Biophys Res Commun 171:690\u2013696","journal-title":"Biochem Biophys Res Commun"},{"key":"2555_CR178","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.15252\/emmm.201404228","volume":"6","author":"M Pascual-Lucas","year":"2014","unstructured":"Pascual-Lucas M, da Silva S, de Scala M, Garcia-Barroso C, Gonz\u00e1lez-Aseguinolaza G, Mulle C, Alberini CM, Cuadrado-Tejedor M, Garcia-Osta A (2014) Insulin-like Growth Factor 2 Reverses Memory and Synaptic Deficits in APP Transgenic Mice. Embo Mol Med 6:1246\u20131262. https:\/\/doi.org\/10.15252\/emmm.201404228","journal-title":"Embo Mol Med"},{"key":"2555_CR179","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.neuron.2014.09.034","volume":"84","author":"JO Lipton","year":"2014","unstructured":"Lipton JO, Sahin M (2014) The Neurology of MTOR. Neuron 84:275\u2013291","journal-title":"Neuron"},{"key":"2555_CR180","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.bbrc.2012.03.033","volume":"420","author":"A Zuleta","year":"2012","unstructured":"Zuleta A, Vidal RL, Armentano D, Parsons G, Hetz C (2012) AAV-Mediated Delivery of the Transcription Factor XBP1s into the Striatum Reduces Mutant Huntingtin Aggregation in a Mouse Model of Huntington\u2019s Disease. Biochem Biophys Res Commun 420:558\u2013563","journal-title":"Biochem Biophys Res Commun"},{"key":"2555_CR181","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1093\/brain\/awx258","volume":"140","author":"F Du","year":"2017","unstructured":"Du F, Yu Q, Yan S, Hu G, Lue L-F, Walker DG, Wu L, Yan SF, Tieu K, Yan SS (2017) PINK1 Signalling Rescues Amyloid Pathology and Mitochondrial Dysfunction in Alzheimer\u2019s Disease. Brain 140:3233\u20133251","journal-title":"Brain"},{"key":"2555_CR182","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/scrt440","volume":"5","author":"M Blurton-Jones","year":"2014","unstructured":"Blurton-Jones M, Spencer B, Michael S, Castello NA, Agazaryan AA, Davis JL, M\u00fcller F-J, Loring JF, Masliah E, LaFerla FM (2014) Neural Stem Cells Genetically-Modified to Express Neprilysin Reduce Pathology in Alzheimer Transgenic Models. Stem Cell Res Ther 5:1\u201314","journal-title":"Stem Cell Res Ther"},{"key":"2555_CR183","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-017-0307-1","volume":"9","author":"R Ghosh","year":"2017","unstructured":"Ghosh R, Tabrizi SJ (2017) Gene Suppression Approaches to Neurodegeneration. Alzheimers Res Ther 9:1\u201313","journal-title":"Alzheimers Res Ther"},{"key":"2555_CR184","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.neuroscience.2012.07.038","volume":"223","author":"DM Hafez","year":"2012","unstructured":"Hafez DM, Huang JY, Richardson JC, Masliah E, Peterson DA, Marr RA (2012) F-Spondin Gene Transfer Improves Memory Performance and Reduces Amyloid-\u03b2 Levels in Mice. Neuroscience 223:465\u2013472","journal-title":"Neuroscience"},{"key":"2555_CR185","doi-asserted-by":"publisher","DOI":"10.1515\/rns.2011.015","volume-title":"Silencing of CDK5 as Potential Therapy for Alzheimer\u2019s Disease","author":"A L\u00f3pez-Tob\u00f3n","year":"2011","unstructured":"L\u00f3pez-Tob\u00f3n A, Castro-\u00c1lvarez JF, Piedrahita D, Boudreau RL, Gallego-G\u00f3mez JC, Cardona-G\u00f3mez GP (2011) Silencing of CDK5 as Potential Therapy for Alzheimer\u2019s Disease"},{"key":"2555_CR186","doi-asserted-by":"publisher","first-page":"27505","DOI":"10.1074\/jbc.M000306200","volume":"275","author":"M Cik","year":"2000","unstructured":"Cik M, Masure S, Lesage AS, Van der Linden I, Van Gompel P, Pangalos MN, Gordon RD, Leysen JE (2000) Binding of GDNF and Neurturin to Human GDNF Family Receptor \u03b1 1 and 2: INFLUENCE OF CRET AND COOPERATIVE INTERACTIONS. J Biol Chem 275:27505\u201327512","journal-title":"J Biol Chem"},{"key":"2555_CR187","doi-asserted-by":"publisher","first-page":"931","DOI":"10.4103\/1673-5374.250570","volume":"14","author":"Y Qu","year":"2019","unstructured":"Qu Y, Liu Y, Noor AF, Tran J, Li R (2019) Characteristics and Advantages of Adeno-Associated Virus Vector-Mediated Gene Therapy for Neurodegenerative Diseases. Neural Regen Res 14:931","journal-title":"Neural Regen Res"},{"key":"2555_CR188","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3727\/096368908784423300","volume":"17","author":"ME Emborg","year":"2008","unstructured":"Emborg ME, Ebert AD, Moirano J, Peng S, Suzuki M, Capowski E, Joers V, Roitberg BZ, Aebischer P, Svendsen CN (2008) GDNF-Secreting Human Neural Progenitor Cells Increase Tyrosine Hydroxylase and VMAT2 Expression in MPTP-Treated Cynomolgus Monkeys. Cell Transplant 17:383\u2013395","journal-title":"Cell Transplant"},{"key":"2555_CR189","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1152\/physrev.00038.2014","volume":"95","author":"J Bockaert","year":"2015","unstructured":"Bockaert J, Marin P (2015) MTOR in Brain Physiology and Pathologies. Physiol Rev 95:1157\u20131187","journal-title":"Physiol Rev"},{"key":"2555_CR190","doi-asserted-by":"publisher","first-page":"6804","DOI":"10.1073\/pnas.1321845111","volume":"111","author":"P Vald\u00e9s","year":"2014","unstructured":"Vald\u00e9s P, Mercado G, Vidal RL, Molina C, Parsons G, Martinez A, Galleguillos D, Armentano D, Schneider BL, Hetz C (2014) Control of Dopaminergic Neuron Survival by the Unfolded Protein Response Transcription Factor XBP1. Proc Natl Acad Sci 111:6804\u20136809","journal-title":"Proc Natl Acad Sci"},{"key":"2555_CR191","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1093\/emboj\/cdg537","volume":"22","author":"C Hetz","year":"2003","unstructured":"Hetz C, Russelakis-Carneiro M, Maundrell K, Castilla J, Soto C (2003) Caspase-12 and Endoplasmic Reticulum Stress Mediate Neurotoxicity of Pathological Prion Protein. EMBO J 22:5435\u20135445","journal-title":"EMBO J"},{"key":"2555_CR192","doi-asserted-by":"publisher","first-page":"38699","DOI":"10.1074\/jbc.M005543200","volume":"275","author":"T Jin","year":"2000","unstructured":"Jin T, Gu Y, Zanusso G, Sy M, Kumar A, Cohen M, Gambetti P, Singh N (2000) The Chaperone Protein BiP Binds to a Mutant Prion Protein and Mediates Its Degradation by the Proteasome. J Biol Chem 275:38699\u201338704","journal-title":"J Biol Chem"},{"key":"2555_CR193","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/sj.gt.3302669","volume":"13","author":"FP Manfredsson","year":"2006","unstructured":"Manfredsson FP, Lewin AS, Mandel RJ (2006) RNA Knockdown as a Potential Therapeutic Strategy in Parkinson\u2019s Disease. Gene Ther 13:517\u2013524","journal-title":"Gene Ther"},{"key":"2555_CR194","doi-asserted-by":"crossref","unstructured":"Bongioanni P, Reali C, Sogos V (2004) Ciliary Neurotrophic Factor (CNTF) for Amyotrophic Lateral Sclerosis or Motor Neuron Disease. Cochrane Database Syst Rev","DOI":"10.1002\/14651858.CD004302.pub2"},{"key":"2555_CR195","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.cytogfr.2015.07.007","volume":"26","author":"S Pasquin","year":"2015","unstructured":"Pasquin S, Sharma M, Gauchat J-F (2015) Ciliary Neurotrophic Factor (CNTF): New Facets of an Old Molecule for Treating Neurodegenerative and Metabolic Syndrome Pathologies. Cytokine Growth Factor Rev 26:507\u2013515","journal-title":"Cytokine Growth Factor Rev"},{"key":"2555_CR196","doi-asserted-by":"publisher","first-page":"e689","DOI":"10.1371\/journal.pone.0000689","volume":"2","author":"M Suzuki","year":"2007","unstructured":"Suzuki M, McHugh J, Tork C, Shelley B, Klein SM, Aebischer P, Svendsen CN (2007) GDNF Secreting Human Neural Progenitor Cells Protect Dying Motor Neurons, but Not Their Projection to Muscle, in a Rat Model of Familial ALS. PloS One 2:e689","journal-title":"PloS One"},{"key":"2555_CR197","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/mt.2013.108","volume":"21","author":"D Krakora","year":"2013","unstructured":"Krakora D, Mulcrone P, Meyer M, Lewis C, Bernau K, Gowing G, Zimprich C, Aebischer P, Svendsen CN, Suzuki M (2013) Synergistic Effects of GDNF and VEGF on Lifespan and Disease Progression in a Familial ALS Rat Model. Mol Ther 21:1602\u20131610","journal-title":"Mol Ther"},{"key":"2555_CR198","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nm0797-765","volume":"3","author":"C Gravel","year":"1997","unstructured":"Gravel C, G\u00f6tz R, Lorrain A, Sendtner M (1997) Adenoviral Gene Transfer of Ciliary Neurotrophic Factor and Brain-Derived Neurotrophic Factor Leads to Long-Term Survival of Axotomized Motor Neurons. Nat Med 3:765\u2013770","journal-title":"Nat Med"},{"key":"2555_CR199","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11910-009-0010-0","volume":"9","author":"J Andrews","year":"2009","unstructured":"Andrews J (2009) Amyotrophic Lateral Sclerosis: Clinical Management and Research Update. Curr Neurol Neurosci Rep 9:59\u201368","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2555_CR200","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.pharmthera.2013.10.009","volume":"141","author":"OP Keifer Jr","year":"2014","unstructured":"Keifer OP Jr, O\u2019Connor DM, Boulis NM (2014) Gene and Protein Therapies Utilizing VEGF for ALS. Pharmacol Ther 141:261\u2013271","journal-title":"Pharmacol Ther"},{"key":"2555_CR201","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1038\/mt.2010.206","volume":"18","author":"JC Dodge","year":"2010","unstructured":"Dodge JC, Treleaven CM, Fidler JA, Hester M, Haidet A, Handy C, Rao M, Eagle A, Matthews JC, Taksir TV (2010) AAV4-Mediated Expression of IGF-1 and VEGF within Cellular Components of the Ventricular System Improves Survival Outcome in Familial ALS Mice. Mol Ther 18:2075\u20132084","journal-title":"Mol Ther"},{"key":"2555_CR202","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1089\/hum.2014.011","volume":"25","author":"MA Passini","year":"2014","unstructured":"Passini MA, Bu J, Richards AM, Treleaven CM, Sullivan JA, O\u2019Riordan CR, Scaria A, Kells AP, Samaranch L, San Sebastian W (2014) Translational Fidelity of Intrathecal Delivery of Self-Complementary AAV9\u2013Survival Motor Neuron 1 for Spinal Muscular Atrophy. Hum Gene Ther 25:619\u2013630","journal-title":"Hum Gene Ther"},{"key":"2555_CR203","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/mt.2014.210","volume":"23","author":"K Meyer","year":"2015","unstructured":"Meyer K, Ferraiuolo L, Schmelzer L, Braun L, McGovern V, Likhite S, Michels O, Govoni A, Fitzgerald J, Morales P et al (2015) Improving Single Injection CSF Delivery of AAV9-Mediated Gene Therapy for SMA: A Dose-Response Study in Mice and Nonhuman Primates. Mol Ther J Am Soc Gene Ther 23:477\u2013487. https:\/\/doi.org\/10.1038\/mt.2014.210","journal-title":"Mol Ther J Am Soc Gene Ther"},{"key":"2555_CR204","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nbt.1610","volume":"28","author":"KD Foust","year":"2010","unstructured":"Foust KD, Wang X, McGovern VL, Braun L, Bevan AK, Haidet AM, Le TT, Morales PR, Rich MM, Burghes AHM et al (2010) Rescue of the Spinal Muscular Atrophy Phenotype in a Mouse Model by Early Postnatal Delivery of SMN. Nat Biotechnol 28:271\u2013274. https:\/\/doi.org\/10.1038\/nbt.1610","journal-title":"Nat Biotechnol"},{"key":"2555_CR205","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41582-018-0051-6","volume":"14","author":"T Ashizawa","year":"2018","unstructured":"Ashizawa T, \u00d6z G, Paulson HL (2018) Spinocerebellar Ataxias: Prospects and Challenges for Therapy Development. Nat Rev Neurol 14:590\u2013605","journal-title":"Nat Rev Neurol"},{"key":"2555_CR206","doi-asserted-by":"publisher","first-page":"7191","DOI":"10.1073\/pnas.0810710106","volume":"106","author":"B Paradiso","year":"2009","unstructured":"Paradiso B, Marconi P, Zucchini S, Berto E, Binaschi A, Bozac A, Buzzi A, Mazzuferi M, Magri E, Mora GN et al (2009) Localized Delivery of Fibroblast Growth Factor\u20132 and Brain-Derived Neurotrophic Factor Reduces Spontaneous Seizures in an Epilepsy Model. Proc Natl Acad Sci 106:7191\u20137196. https:\/\/doi.org\/10.1073\/pnas.0810710106","journal-title":"Proc Natl Acad Sci"},{"key":"2555_CR207","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1742-2094-7-81","volume":"7","author":"R Bovolenta","year":"2010","unstructured":"Bovolenta R, Zucchini S, Paradiso B, Rodi D, Merigo F, Mora GN, Osculati F, Berto E, Marconi P, Marzola A et al (2010) Hippocampal FGF-2 and BDNF Overexpression Attenuates Epileptogenesis-Associated Neuroinflammation and Reduces Spontaneous Recurrent Seizures. J Neuroinflammation 7:81. https:\/\/doi.org\/10.1186\/1742-2094-7-81","journal-title":"J Neuroinflammation"},{"key":"2555_CR208","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/j.1528-1167.2010.02930.x","volume":"52","author":"B Paradiso","year":"2011","unstructured":"Paradiso B, Zucchini S, Su T, Bovolenta R, Berto E, Marconi P, Marzola A, Mora GN, Fabene PF, Simonato M (2011) Localized Overexpression of FGF-2 and BDNF in Hippocampus Reduces Mossy Fiber Sprouting and Spontaneous Seizures up to 4 Weeks after Pilocarpine-Induced Status Epilepticus. Epilepsia 52:572\u2013578. https:\/\/doi.org\/10.1111\/j.1528-1167.2010.02930.x","journal-title":"Epilepsia"},{"key":"2555_CR209","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/nm901","volume":"9","author":"RP Haberman","year":"2003","unstructured":"Haberman RP, Samulski RJ, McCown TJ (2003) Attenuation of Seizures and Neuronal Death by Adeno-Associated Virus Vector Galanin Expression and Secretion. Nat Med 9:1076\u20131080. https:\/\/doi.org\/10.1038\/nm901","journal-title":"Nat Med"},{"key":"2555_CR210","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1046\/j.1460-9568.2003.02926.x","volume":"18","author":"E-JD Lin","year":"2003","unstructured":"Lin E-JD, Richichi C, Young D, Baer K, Vezzani A, During MJ (2003) Recombinant AAV-Mediated Expression of Galanin in Rat Hippocampus Suppresses Seizure Development. Eur J Neurosci 18:2087\u20132092. https:\/\/doi.org\/10.1046\/j.1460-9568.2003.02926.x","journal-title":"Eur J Neurosci"},{"key":"2555_CR211","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ymthe.2006.04.004","volume":"14","author":"TJ McCown","year":"2006","unstructured":"McCown TJ (2006) Adeno-Associated Virus-Mediated Expression and Constitutive Secretion of Galanin Suppresses Limbic Seizure Activity <em>in Vivo<\/Em>. Mol Ther 14:63\u201368. https:\/\/doi.org\/10.1016\/j.ymthe.2006.04.004","journal-title":"Mol Ther"},{"key":"2555_CR212","doi-asserted-by":"publisher","first-page":"11342","DOI":"10.1523\/JNEUROSCI.3329-06.2006","volume":"26","author":"YH Raol","year":"2006","unstructured":"Raol YH, Lund IV, Bandyopadhyay S, Zhang G, Roberts DS, Wolfe JH, Russek SJ, Brooks-Kayal AR (2006) Enhancing GABAA Receptor \u03911 Subunit Levels in Hippocampal Dentate Gyrus Inhibits Epilepsy Development in an Animal Model of Temporal Lobe Epilepsy. J Neurosci 26:11342\u201311346","journal-title":"J Neurosci"},{"key":"2555_CR213","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1038\/d41586-018-07644-y","volume":"564","author":"L Drew","year":"2018","unstructured":"Drew L (2018) Gene Therapy Targets Epilepsy. Nature 564:S10\u2013S11","journal-title":"Nature"},{"key":"2555_CR214","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/mtna.2016.7","volume":"5","author":"J Miniarikova","year":"2016","unstructured":"Miniarikova J, Zanella I, Huseinovic A, van der Zon T, Hanemaaijer E, Martier R, Koornneef A, Southwell AL, Hayden MR, van Deventer SJ (2016) Design, Characterization, and Lead Selection of Therapeutic MiRNAs Targeting Huntingtin for Development of Gene Therapy for Huntington\u2019s Disease. Mol Ther Nucleic Acids 5:297","journal-title":"Mol Ther Nucleic Acids"},{"key":"2555_CR215","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/gt.2017.71","volume":"24","author":"J Miniarikova","year":"2017","unstructured":"Miniarikova J, Zimmer V, Martier R, Brouwers CC, Pythoud C, Richetin K, Rey M, Lubelski J, Evers MM, van Deventer SJ (2017) AAV5-MiHTT Gene Therapy Demonstrates Suppression of Mutant Huntingtin Aggregation and Neuronal Dysfunction in a Rat Model of Huntington\u2019s Disease. Gene Ther 24:630\u2013639","journal-title":"Gene Ther"},{"key":"2555_CR216","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.ymthe.2018.06.021","volume":"26","author":"MM Evers","year":"2018","unstructured":"Evers MM, Miniarikova J, Juhas S, Vall\u00e8s A, Bohuslavova B, Juhasova J, Skalnikova HK, Vodicka P, Valekova I, Brouwers C (2018) AAV5-MiHTT Gene Therapy Demonstrates Broad Distribution and Strong Human Mutant Huntingtin Lowering in a Huntington\u2019s Disease Minipig Model. Mol Ther 26:2163\u20132177","journal-title":"Mol Ther"},{"key":"2555_CR217","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1177\/096368970000900507","volume":"9","author":"NS Haque","year":"2000","unstructured":"Haque NS, Isacson O (2000) Neurotrophic Factors NGF and FGF-2 Alter Levels of Huntingtin (IT15) in Striatal Neuronal Cell Cultures. Cell Transplant 9:623\u2013627","journal-title":"Cell Transplant"},{"key":"2555_CR218","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1006\/nbdi.2001.0388","volume":"8","author":"LP de Almeida","year":"2001","unstructured":"de Almeida LP, Zala D, Aebischer P, D\u00e9glon N (2001) Neuroprotective Effect of a CNTF-Expressing Lentiviral Vector in the Quinolinic Acid Rat Model of Huntington\u2019s Disease. Neurobiol Dis 8:433\u2013446. https:\/\/doi.org\/10.1006\/nbdi.2001.0388","journal-title":"Neurobiol Dis"},{"key":"2555_CR219","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.expneurol.2010.03.005","volume":"224","author":"AD Ebert","year":"2010","unstructured":"Ebert AD, Barber AE, Heins BM, Svendsen CN (2010) Ex Vivo Delivery of GDNF Maintains Motor Function and Prevents Neuronal Loss in a Transgenic Mouse Model of Huntington\u2019s Disease. Exp Neurol 224:155\u2013162","journal-title":"Exp Neurol"},{"key":"2555_CR220","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/sj.gt.3302847","volume":"14","author":"JR Pineda","year":"2007","unstructured":"Pineda JR, Rubio N, Akerud P, Urban N, Badimon L, Arenas E, Alberch J, Blanco J, Canals JM (2007) Neuroprotection by GDNF-Secreting Stem Cells in a Huntington\u2019s Disease Model: Optical Neuroimage Tracking of Brain-Grafted Cells. Gene Ther 14:118\u2013128","journal-title":"Gene Ther"},{"key":"2555_CR221","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.brainres.2008.11.104","volume":"1257","author":"M Sado","year":"2009","unstructured":"Sado M, Yamasaki Y, Iwanaga T, Onaka Y, Ibuki T, Nishihara S, Mizuguchi H, Momota H, Kishibuchi R, Hashimoto T (2009) Protective Effect against Parkinson\u2019s Disease-Related Insults through the Activation of XBP1. Brain Res 1257:16\u201324","journal-title":"Brain Res"},{"key":"2555_CR222","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.neuron.2012.06.001","volume":"74","author":"X-H Lu","year":"2012","unstructured":"Lu X-H, Yang XW (2012) \u201cHuntingtin Holiday\u201d: Progress toward an Antisense Therapy for Huntington\u2019s Disease. Neuron 74:964\u2013966","journal-title":"Neuron"},{"key":"2555_CR223","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1161\/01.STR.0000070840.56414.3B","volume":"34","author":"N Matsuoka","year":"2003","unstructured":"Matsuoka N, Nozaki K, Takagi Y, Nishimura M, Hayashi J, Miyatake S-I, Hashimoto N (2003) Adenovirus-Mediated Gene Transfer of Fibroblast Growth Factor-2 Increases BrdU-Positive Cells after Forebrain Ischemia in Gerbils. Stroke 34:1519\u20131525","journal-title":"Stroke"},{"key":"2555_CR224","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1161\/01.STR.0000236025.44089.e1","volume":"37","author":"K Tohru","year":"2006","unstructured":"Tohru K, Henrik A, P\u00e4r T, Rina K, Zaal K, Olle L (2006) Intracerebral Infusion of Glial Cell Line-Derived Neurotrophic Factor Promotes Striatal Neurogenesis After Stroke in Adult Rats. Stroke 37:2361\u20132367. https:\/\/doi.org\/10.1161\/01.STR.0000236025.44089.e1","journal-title":"Stroke"},{"key":"2555_CR225","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nrneurol.2009.54","volume":"5","author":"C Zuccato","year":"2009","unstructured":"Zuccato C, Cattaneo E (2009) Brain-Derived Neurotrophic Factor in Neurodegenerative Diseases. Nat Rev Neurol 5:311","journal-title":"Nat Rev Neurol"},{"key":"2555_CR226","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/ana.410440403","volume":"44","author":"MA Yenari","year":"1998","unstructured":"Yenari MA, Fink SL, Sun GH, Chang LK, Patel MK, Kunis DM, Onley D, Ho DY, Sapolsky RM, Steinbrg GK (1998) Gene Therapy with HSP72 Is Neuroprotective in Rat Models of Stroke and Epilepsy. Ann Neurol 44:584\u2013591. https:\/\/doi.org\/10.1002\/ana.410440403","journal-title":"Ann Neurol"},{"key":"2555_CR227","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1161\/01.STR.28.12.2425","volume":"28","author":"S Matthias","year":"1997","unstructured":"Matthias S, Sebastian K, Stefan S, Sybille D, Werner H (1997) Superoxide Dismutase Activity in Serum of Patients With Acute Cerebral Ischemic Injury. Stroke 28:2425\u20132428. https:\/\/doi.org\/10.1161\/01.STR.28.12.2425","journal-title":"Stroke"},{"key":"2555_CR228","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1080\/14737159.2020.1826313","volume":"20","author":"Q Wang","year":"2020","unstructured":"Wang Q, Liu X, Zhao J, Zhu R (2020) Circular RNAs: Novel Diagnostic and Therapeutic Targets for Ischemic Stroke. Expert Rev Mol Diagn 20:1039\u20131049","journal-title":"Expert Rev Mol Diagn"},{"key":"2555_CR229","doi-asserted-by":"crossref","unstructured":"Zavvarian, M.-M.; Toossi, A.; Khazaei, M.; Hong, J.; Fehlings, M. Novel Innovations in Cell and Gene Therapies for Spinal Cord Injury. F1000Research 2020, 9.","DOI":"10.12688\/f1000research.21989.1"},{"key":"2555_CR230","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41434-019-0073-8","volume":"27","author":"D Blanco-Ocampo","year":"2020","unstructured":"Blanco-Ocampo D, Cawen FA, \u00c1lamo-Pindado LA, Negro-Demontel ML, Peluffo H (2020) Safe and Neuroprotective Vectors for Long-Term Traumatic Brain Injury Gene Therapy. Gene Ther 27:96\u2013103","journal-title":"Gene Ther"},{"key":"2555_CR231","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s10143-007-0094-4","volume":"30","author":"F Shen","year":"2007","unstructured":"Shen F, Wen L, Yang X, Liu W (2007) The Potential Application of Gene Therapy in the Treatment of Traumatic Brain Injury. Neurosurg Rev 30:291\u2013298","journal-title":"Neurosurg Rev"},{"key":"2555_CR232","doi-asserted-by":"publisher","first-page":"1900177","DOI":"10.1002\/ardp.201900177","volume":"352","author":"B Mathew","year":"2019","unstructured":"Mathew B, Parambi DGT, Mathew GE, Uddin MdS, Inasu ST, Kim H, Marathakam A, Unnikrishnan MK, Carradori S (2019) Emerging Therapeutic Potentials of Dual-Acting MAO and AChE Inhibitors in Alzheimer\u2019s and Parkinson\u2019s Diseases. Arch Pharm (Weinheim) 352:1900177. https:\/\/doi.org\/10.1002\/ardp.201900177","journal-title":"Arch Pharm (Weinheim)"},{"key":"2555_CR233","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1111\/jphp.13132","volume":"71","author":"S Harilal","year":"2019","unstructured":"Harilal S, Jose J, Parambi DGT, Kumar R, Mathew GE, Uddin MdS, Kim H, Mathew B (2019) Advancements in Nanotherapeutics for Alzheimer\u2019s Disease: Current Perspectives. J Pharm Pharmacol 71:1370\u20131383. https:\/\/doi.org\/10.1111\/jphp.13132","journal-title":"J Pharm Pharmacol"},{"key":"2555_CR234","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1523\/JNEUROSCI.10-12-03801.1990","volume":"10","author":"VE Koliatsos","year":"1990","unstructured":"Koliatsos VE, Nauta HJ, Clatterbuck RE, Holtzman DM, Mobley WC, Price DL (1990) Mouse Nerve Growth Factor Prevents Degeneration of Axotomized Basal Forebrain Cholinergic Neurons in the Monkey. J. Neurosci. 10:3801\u20133813. https:\/\/doi.org\/10.1523\/JNEUROSCI.10-12-03801.1990","journal-title":"J. Neurosci."},{"key":"2555_CR235","doi-asserted-by":"publisher","first-page":"10898","DOI":"10.1073\/pnas.91.23.10898","volume":"91","author":"JH Kordower","year":"1994","unstructured":"Kordower JH, Winn SR, Liu YT, Mufson EJ, Sladek JR Jr, Hammang JP, Baetge EE, Emerich DF (1994) The Aged Monkey Basal Forebrain: Rescue and Sprouting of Axotomized Basal Forebrain Neurons after Grafts of Encapsulated Cells Secreting Human Nerve Growth Factor. Proc Natl Acad Sci U S A 91:10898\u201310902. https:\/\/doi.org\/10.1073\/pnas.91.23.10898","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2555_CR236","doi-asserted-by":"publisher","DOI":"10.2174\/0929867327666200121165931","author":"B Mathew","year":"2020","unstructured":"Mathew B, Carradori S, Guglielmi P, Uddin MdS, Kim H (2020) New Aspects of Monoamine Oxidase B Inhibitors: The Key Role of Halogens to Open the Golden Door. Curr Med Chem. https:\/\/doi.org\/10.2174\/0929867327666200121165931","journal-title":"Curr Med Chem"},{"key":"2555_CR237","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.carbpol.2009.08.026","volume":"79","author":"R Jayakumar","year":"2010","unstructured":"Jayakumar R, Chennazhi KP, Muzzarelli RAA, Tamura H, Nair SV, Selvamurugan N (2010) Chitosan Conjugated DNA Nanoparticles in Gene Therapy. Carbohydr Polym 79:1\u20138. https:\/\/doi.org\/10.1016\/j.carbpol.2009.08.026","journal-title":"Carbohydr Polym"},{"key":"2555_CR238","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1001\/jamaneurol.2015.1807","volume":"72","author":"MH Tuszynski","year":"2015","unstructured":"Tuszynski MH, Yang JH, Barba D, Hoi-Sang U, Bakay RA, Pay MM, Masliah E, Conner JM, Kobalka P, Roy S (2015) Nerve Growth Factor Gene Therapy: Activation of Neuronal Responses in Alzheimer Disease. JAMA Neurol 72:1139\u20131147","journal-title":"JAMA Neurol"},{"key":"2555_CR239","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"C-C Wu","year":"2016","unstructured":"Wu C-C, Lien C-C, Hou W-H, Chiang P-M, Tsai K-J (2016) Gain of BDNF Function in Engrafted Neural Stem Cells Promotes the Therapeutic Potential for Alzheimer\u2019s Disease. Sci Rep 6:1\u201316","journal-title":"Sci Rep"},{"key":"2555_CR240","doi-asserted-by":"publisher","first-page":"379","DOI":"10.5966\/sctm.2015-0103","volume":"5","author":"LM McGinley","year":"2016","unstructured":"McGinley LM, Sims E, Lunn JS, Kashlan ON, Chen KS, Bruno ES, Pacut CM, Hazel T, Johe K, Sakowski SA (2016) Human Cortical Neural Stem Cells Expressing Insulin-like Growth Factor-I: A Novel Cellular Therapy for Alzheimer\u2019s Disease. Stem Cells Transl Med 5:379\u2013391","journal-title":"Stem Cells Transl Med"},{"key":"2555_CR241","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.neurobiolaging.2010.03.024","volume":"33","author":"HJ Lee","year":"2012","unstructured":"Lee HJ, Lee JK, Lee H, Carter JE, Chang JW, Oh W, Yang YS, Suh J-G, Lee B-H, Jin HK (2012) Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Improve Neuropathology and Cognitive Impairment in an Alzheimer\u2019s Disease Mouse Model through Modulation of Neuroinflammation. Neurobiol Aging 33:588\u2013602","journal-title":"Neurobiol Aging"},{"key":"2555_CR242","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/nan.12319","volume":"43","author":"Y Naaldijk","year":"2017","unstructured":"Naaldijk Y, Jaeger C, Fabian C, Leovsky C, Bl\u00fcher A, Rudolph L, Hinze A, Stolzing A (2017) Effect of Systemic Transplantation of Bone Marrow-Derived Mesenchymal Stem Cells on Neuropathology Markers in APP\/PS 1 Alzheimer Mice. Neuropathol Appl Neurobiol 43:299\u2013314","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2555_CR243","doi-asserted-by":"publisher","first-page":"E1339","DOI":"10.1073\/pnas.1102349108","volume":"108","author":"T Kiyota","year":"2011","unstructured":"Kiyota T, Ingraham KL, Jacobsen MT, Xiong H, Ikezu T (2011) FGF2 Gene Transfer Restores Hippocampal Functions in Mouse Models of Alzheimer\u2019s Disease and Has Therapeutic Implications for Neurocognitive Disorders. Proc Natl Acad Sci 108:E1339\u2013E1348","journal-title":"Proc Natl Acad Sci"},{"key":"2555_CR244","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/nan.12338","volume":"43","author":"CJ Garwood","year":"2017","unstructured":"Garwood CJ, Ratcliffe LE, Simpson JE, Heath PR, Ince PG, Wharton SB (2017) Astrocytes in Alzheimer\u2019s Disease and Other Age-Associated Dementias: A Supporting Player with a Central Role. Neuropathol Appl Neurobiol 43:281\u2013298","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2555_CR245","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.tins.2015.08.008","volume":"38","author":"M-V Guillot-Sestier","year":"2015","unstructured":"Guillot-Sestier M-V, Doty KR, Town T (2015) Innate Immunity Fights Alzheimer\u2019s Disease. Trends Neurosci 38:674\u2013681","journal-title":"Trends Neurosci"},{"key":"2555_CR246","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.cellsig.2015.02.018","volume":"27","author":"M-A Lauzon","year":"2015","unstructured":"Lauzon M-A, Daviau A, Marcos B, Faucheux N (2015) Growth Factor Treatment to Overcome Alzheimer\u2019s Dysfunctional Signaling. Cell Signal 27:1025\u20131038","journal-title":"Cell Signal"},{"key":"2555_CR247","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/jnc.13411","volume":"136","author":"MR Minter","year":"2016","unstructured":"Minter MR, Taylor JM, Crack PJ (2016) The Contribution of Neuroinflammation to Amyloid Toxicity in Alzheimer\u2019s Disease. J Neurochem 136:457\u2013474","journal-title":"J Neurochem"},{"key":"2555_CR248","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s10142-011-0238-z","volume":"11","author":"PKK Namboori","year":"2011","unstructured":"Namboori PKK, Vineeth KV, Rohith V, Hassan I, Sekhar L, Sekhar A, Nidheesh M (2011) The ApoE Gene of Alzheimer\u2019s Disease (AD). Funct Integr Genomics 11:519\u2013522. https:\/\/doi.org\/10.1007\/s10142-011-0238-z","journal-title":"Funct Integr Genomics"},{"key":"2555_CR249","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1038\/mt.2013.118","volume":"21","author":"SR Murphy","year":"2013","unstructured":"Murphy SR, Chang CCY, Dogbevia G, Bryleva EY, Bowen Z, Hasan MT, Chang T-Y (2013) Acat1 Knockdown Gene Therapy Decreases Amyloid-\u03b2 in a Mouse Model of Alzheimer\u2019s Disease. Mol Ther 21:1497\u20131506. https:\/\/doi.org\/10.1038\/mt.2013.118","journal-title":"Mol Ther"},{"key":"2555_CR250","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2183\/pjab.89.321","volume":"89","author":"TC Saido","year":"2013","unstructured":"Saido TC (2013) Metabolism of Amyloid \u03b2 Peptide and Pathogenesis of Alzheimer\u2019s Disease. Proc Jpn Acad Ser B Phys Biol Sci 89:321\u2013339. https:\/\/doi.org\/10.2183\/pjab.89.321","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"2555_CR251","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1038\/srep01472","volume":"3","author":"N Iwata","year":"2013","unstructured":"Iwata N, Sekiguchi M, Hattori Y, Takahashi A, Asai M, Ji B, Higuchi M, Staufenbiel M, Muramatsu S, Saido TC (2013) Global Brain Delivery of Neprilysin Gene by Intravascular Administration of AAV Vector in Mice. Sci Rep 3:1472. https:\/\/doi.org\/10.1038\/srep01472","journal-title":"Sci Rep"},{"key":"2555_CR252","doi-asserted-by":"publisher","first-page":"e59626","DOI":"10.1371\/journal.pone.0059626","volume":"8","author":"N Carty","year":"2013","unstructured":"Carty N, Nash KR, Brownlow M, Cruite D, Wilcock D, Selenica M-LB, Lee DC, Gordon MN, Morgan D (2013) Intracranial Injection of AAV Expressing NEP but Not IDE Reduces Amyloid Pathology in APP+PS1 Transgenic Mice. PLOS ONE 8:e59626","journal-title":"PLOS ONE"},{"key":"2555_CR253","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.3233\/JAD-2010-1298","volume":"19","author":"G Marwarha","year":"2010","unstructured":"Marwarha G, Dasari B, Prasanthi JRP, Schommer J, Ghribi O (2010) Leptin Reduces the Accumulation of Abeta and Phosphorylated Tau Induced by 27-Hydroxycholesterol in Rabbit Organotypic Slices. J Alzheimers Dis JAD 19:1007\u20131019. https:\/\/doi.org\/10.3233\/JAD-2010-1298","journal-title":"J Alzheimers Dis JAD"},{"issue":"10","key":"2555_CR254","doi-asserted-by":"publisher","first-page":"961","DOI":"10.2174\/1567205011666141107150938","volume":"11","author":"Q Zhang","year":"2014","unstructured":"Zhang Q, Li N, Jiao X, Qin X, Kaur R, Lu X, Song J, Wang L, Wang J, Niu Q (2014) Caspase-3 Short Hairpin RNAs: A Potential Therapeutic Agent in Neurodegeneration of Aluminum-Exposed Animal Model. Curr Alzheimer Res 11(10):961\u2013970","journal-title":"Curr Alzheimer Res"},{"key":"2555_CR255","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.4103\/1673-5374.135317","volume":"9","author":"X Chai","year":"2014","unstructured":"Chai X, Kong W, Liu L, Yu W, Zhang Z, Sun Y (2014) A Viral Vector Expressing Hypoxia-Inducible Factor 1 Alpha Inhibits Hippocampal Neuronal Apoptosis. Neural Regen Res 9:1145\u20131153. https:\/\/doi.org\/10.4103\/1673-5374.135317","journal-title":"Neural Regen Res"},{"key":"2555_CR256","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1002\/ana.10513","volume":"53","author":"O Rascol","year":"2003","unstructured":"Rascol O, Payoux P, Ory F, Ferreira JJ, Brefel-Courbon C, Montastruc J-L (2003) Limitations of Current Parkinson\u2019s Disease Therapy. Ann Neurol 53:S3\u2013S15. https:\/\/doi.org\/10.1002\/ana.10513","journal-title":"Ann Neurol"},{"key":"2555_CR257","first-page":"706","volume":"60","author":"JH Kordower","year":"2006","unstructured":"Kordower JH, Herzog CD, Dass B, Bakay RA, Stansell J III, Gasmi M, Bartus RT (2006) Delivery of Neurturin by AAV2 (CERE-120)-Mediated Gene Transfer Provides Structural and Functional Neuroprotection and Neurorestoration in MPTP-Treated Monkeys. Ann Neurol Off J Am Neurol Assoc Child Neurol Soc 60:706\u2013715","journal-title":"Ann Neurol Off J Am Neurol Assoc Child Neurol Soc"},{"key":"2555_CR258","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1212\/WNL.66.10_suppl_4.S89","volume":"66","author":"B Dass","year":"2006","unstructured":"Dass B, Olanow CW, Kordower JH (2006) Gene Transfer of Trophic Factors and Stem Cell Grafting as Treatments for Parkinson\u2019s Disease. Neurology 66:S89\u2013S103","journal-title":"Neurology"},{"key":"2555_CR259","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/ana.20737","volume":"59","author":"AE Lang","year":"2006","unstructured":"Lang AE, Gill S, Patel NK, Lozano A, Nutt JG, Penn R, Brooks DJ, Hotton G, Moro E, Heywood P (2006) Randomized Controlled Trial of Intraputamenal Glial Cell Line-Derived Neurotrophic Factor Infusion in Parkinson Disease. Ann Neurol 59:459\u2013466","journal-title":"Ann Neurol"},{"key":"2555_CR260","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1126\/science.290.5492.767","volume":"290","author":"JH Kordower","year":"2000","unstructured":"Kordower JH, Emborg ME, Bloch J, Ma SY, Chu Y, Leventhal L, McBride J, Chen E-Y, Palfi S, Roitberg BZ (2000) Neurodegeneration Prevented by Lentiviral Vector Delivery of GDNF in Primate Models of Parkinson\u2019s Disease. Science 290:767\u2013773","journal-title":"Science"},{"key":"2555_CR261","doi-asserted-by":"publisher","first-page":"26473","DOI":"10.3390\/ijms161125966","volume":"16","author":"F-X Zuo","year":"2015","unstructured":"Zuo F-X, Bao X-J, Sun X-C, Wu J, Bai Q-R, Chen G, Li X-Y, Zhou Q-Y, Yang Y-F, Shen Q (2015) Transplantation of Human Neural Stem Cells in a Parkinsonian Model Exerts Neuroprotection via Regulation of the Host Microenvironment. Int J Mol Sci 16:26473\u201326492","journal-title":"Int J Mol Sci"},{"key":"2555_CR262","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.expneurol.2007.09.022","volume":"209","author":"AD Ebert","year":"2008","unstructured":"Ebert AD, Beres AJ, Barber AE, Svendsen CN (2008) Human Neural Progenitor Cells Over-Expressing IGF-1 Protect Dopamine Neurons and Restore Function in a Rat Model of Parkinson\u2019s Disease. Exp Neurol 209:213\u2013223","journal-title":"Exp Neurol"},{"key":"2555_CR263","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.neuroscience.2014.11.060","volume":"286","author":"R Rumpel","year":"2015","unstructured":"Rumpel R, Hohmann M, Klein A, Wesemann M, Baumg\u00e4rtner W, Ratzka A, Grothe C (2015) Transplantation of Fetal Ventral Mesencephalic Progenitor Cells Overexpressing High Molecular Weight Fibroblast Growth Factor 2 Isoforms in 6-Hydroxydopamine Lesioned Rats. Neuroscience 286:293\u2013307","journal-title":"Neuroscience"},{"key":"2555_CR264","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.expneurol.2013.03.016","volume":"247","author":"A Glavaski-Joksimovic","year":"2013","unstructured":"Glavaski-Joksimovic A, Bohn MC (2013) Mesenchymal Stem Cells and Neuroregeneration in Parkinson\u2019s Disease. Exp Neurol 247:25\u201338","journal-title":"Exp Neurol"},{"key":"2555_CR265","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nm850","volume":"9","author":"SS Gill","year":"2003","unstructured":"Gill SS, Patel NK, Hotton GR, O\u2019Sullivan K, McCarter R, Bunnage M, Brooks DJ, Svendsen CN, Heywood P (2003) Direct Brain Infusion of Glial Cell Line-Derived Neurotrophic Factor in Parkinson Disease. Nat Med 9:589\u2013595","journal-title":"Nat Med"},{"key":"2555_CR266","first-page":"401","volume":"102","author":"DM Gash","year":"2005","unstructured":"Gash DM, Kryscio R, Young B (2005) Research on Parkinson Disease. J Neurosurg 102:401","journal-title":"J Neurosurg"},{"key":"2555_CR267","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1177\/01926230701481899a","volume":"35","author":"DN Hovland","year":"2007","unstructured":"Hovland DN, Boyd RB, Butt MT, Engelhardt JA, Moxness MS, Ma MH, Emery MG, Ernst NB, Reed RP, Zeller JR et al (2007) Six-Month Continuous Intraputamenal Infusion Toxicity Study of Recombinant Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-MetHuGDNF) in Rhesus Monkeys. Toxicol Pathol 35:676\u2013692. https:\/\/doi.org\/10.1177\/01926230701481899a","journal-title":"Toxicol Pathol"},{"key":"2555_CR268","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1038\/mt.2009.196","volume":"17","author":"FP Manfredsson","year":"2009","unstructured":"Manfredsson FP, Burger C, Rising AC, Zuobi-Hasona K, Sullivan LF, Lewin AS, Huang J, Piercefield E, Muzyczka N, Mandel RJ (2009) Tight Long-Term Dynamic Doxycycline Responsive Nigrostriatal GDNF Using a Single RAAV Vector. Mol Ther 17:1857\u20131867. https:\/\/doi.org\/10.1038\/mt.2009.196","journal-title":"Mol Ther"},{"key":"2555_CR269","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1046\/j.1460-9568.2003.02456.x","volume":"17","author":"C Rosenblad","year":"2003","unstructured":"Rosenblad C, Georgievska B, Kirik D (2003) Long-Term Striatal Overexpression of GDNF Selectively Downregulates Tyrosine Hydroxylase in the Intact Nigrostriatal Dopamine System. Eur J Neurosci 17:260\u2013270. https:\/\/doi.org\/10.1046\/j.1460-9568.2003.02456.x","journal-title":"Eur J Neurosci"},{"key":"2555_CR270","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1038\/mt.2013.169","volume":"21","author":"L Quintino","year":"2013","unstructured":"Quintino L, Manfr\u00e9 G, Wettergren EE, Namislo A, Isaksson C, Lundberg C (2013) Functional Neuroprotection and Efficient Regulation of GDNF Using Destabilizing Domains in a Rodent Model of Parkinson\u2019s Disease. Mol Ther J Am Soc Gene Ther. 21:2169\u20132180. https:\/\/doi.org\/10.1038\/mt.2013.169","journal-title":"Mol Ther J Am Soc Gene Ther."},{"key":"2555_CR271","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.chembiol.2010.07.009","volume":"17","author":"M Iwamoto","year":"2010","unstructured":"Iwamoto M, Bj\u00f6rklund T, Lundberg C, Kirik D, Wandless TJ (2010) A General Chemical Method to Regulate Protein Stability in the Mammalian Central Nervous System. Chem Biol 17:981\u2013988. https:\/\/doi.org\/10.1016\/j.chembiol.2010.07.009","journal-title":"Chem Biol"},{"key":"2555_CR272","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.nbd.2011.05.026","volume":"44","author":"RT Bartus","year":"2011","unstructured":"Bartus RT, Brown L, Wilson A, Kruegel B, Siffert J, Johnson EM, Kordower JH, Herzog CD (2011) Properly Scaled and Targeted AAV2-NRTN (Neurturin) to the Substantia Nigra Is Safe, Effective and Causes No Weight Loss: Support for Nigral Targeting in Parkinson\u2019s Disease. Neurobiol Dis 44:38\u201352. https:\/\/doi.org\/10.1016\/j.nbd.2011.05.026","journal-title":"Neurobiol Dis"},{"key":"2555_CR273","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.ymthe.2006.05.005","volume":"14","author":"KS Bankiewicz","year":"2006","unstructured":"Bankiewicz KS, Forsayeth J, Eberling JL, Sanchez-Pernaute R, Pivirotto P, Bringas J, Herscovitch P, Carson RE, Eckelman W, Reutter B (2006) Long-Term Clinical Improvement in MPTP-Lesioned Primates after Gene Therapy with AAV-HAADC. Mol Ther 14:564\u2013570","journal-title":"Mol Ther"},{"key":"2555_CR274","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1038\/mt.2010.106","volume":"18","author":"P Hadaczek","year":"2010","unstructured":"Hadaczek P, Eberling JL, Pivirotto P, Bringas J, Forsayeth J, Bankiewicz KS (2010) Eight Years of Clinical Improvement in MPTP-Lesioned Primates after Gene Therapy with AAV2-HAADC. Mol Ther 18:1458\u20131461","journal-title":"Mol Ther"},{"key":"2555_CR275","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.ymthe.2006.04.008","volume":"14","author":"JR Forsayeth","year":"2006","unstructured":"Forsayeth JR, Eberling JL, Sanftner LM, Zhen Z, Pivirotto P, Bringas J, Cunningham J, Bankiewicz KS (2006) A Dose-Ranging Study of AAV-HAADC Therapy in Parkinsonian Monkeys. Mol Ther 14:571\u2013577","journal-title":"Mol Ther"},{"key":"2555_CR276","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1089\/hum.2011.162","volume":"23","author":"W San Sebastian","year":"2012","unstructured":"San Sebastian W, Richardson RM, Kells AP, Lamarre C, Bringas J, Pivirotto P, Salegio EA, DeArmond SJ, Forsayeth J, Bankiewicz KS (2012) Safety and Tolerability of Magnetic Resonance Imaging-Guided Convection-Enhanced Delivery of AAV2-HAADC with a Novel Delivery Platform in Nonhuman Primate Striatum. Hum Gene Ther 23:210\u2013217","journal-title":"Hum Gene Ther"},{"key":"2555_CR277","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1006\/exnr.2000.7408","volume":"164","author":"KS Bankiewicz","year":"2000","unstructured":"Bankiewicz KS, Eberling JL, Kohutnicka M, Jagust W, Pivirotto P, Bringas J, Cunningham J, Budinger TF, Harvey-White J (2000) Convection-Enhanced Delivery of AAV Vector in Parkinsonian Monkeys; in Vivo Detection of Gene Expression and Restoration of Dopaminergic Function Using pro-Drug Approach. Exp Neurol 164:2\u201314","journal-title":"Exp Neurol"},{"key":"2555_CR278","doi-asserted-by":"publisher","first-page":"10302","DOI":"10.1523\/JNEUROSCI.22-23-10302.2002","volume":"22","author":"M Azzouz","year":"2002","unstructured":"Azzouz M, Martin-Rendon E, Barber RD, Mitrophanous KA, Carter EE, Rohll JB, Kingsman SM, Kingsman AJ, Mazarakis ND (2002) Multicistronic Lentiviral Vector-Mediated Striatal Gene Transfer of Aromatic L-Amino Acid Decarboxylase, Tyrosine Hydroxylase, and GTP Cyclohydrolase I Induces Sustained Transgene Expression, Dopamine Production, and Functional Improvement in a Rat Model. J Neurosci Off J Soc Neurosci 22:10302\u201310312. https:\/\/doi.org\/10.1523\/JNEUROSCI.22-23-10302.2002","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"2555_CR279","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1089\/hum.2011.220","volume":"23","author":"G Mittermeyer","year":"2012","unstructured":"Mittermeyer G, Christine CW, Rosenbluth KH, Baker SL, Starr P, Larson P, Kaplan PL, Forsayeth J, Aminoff MJ, Bankiewicz KS (2012) Long-Term Evaluation of a Phase 1 Study of AADC Gene Therapy for Parkinson\u2019s Disease. Hum Gene Ther 23:377\u2013381. https:\/\/doi.org\/10.1089\/hum.2011.220","journal-title":"Hum Gene Ther"},{"key":"2555_CR280","doi-asserted-by":"publisher","first-page":"14049","DOI":"10.1038\/mtm.2014.49","volume":"3","author":"WS Sebastian","year":"2014","unstructured":"Sebastian WS, Kells AP, Bringas J, Samaranch L, Hadaczek P, Ciesielska A, Macayan MJ, Pivirotto PJ, Forsayeth J, Osborne S et al (2014) Safety and Tolerability of MRI-Guided Infusion of AAV2-HAADC into the Mid-Brain of Nonhuman Primate. Mol. Ther. - Methods Clin. Dev. 3:14049. https:\/\/doi.org\/10.1038\/mtm.2014.49","journal-title":"Mol. Ther. - Methods Clin. Dev."},{"key":"2555_CR281","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/mt.2012.1","volume":"20","author":"E Cederfj\u00e4ll","year":"2012","unstructured":"Cederfj\u00e4ll E, Sahin G, Kirik D, Bj\u00f6rklund T (2012) Design of a Single AAV Vector for Coexpression of TH and GCH1 to Establish Continuous DOPA Synthesis in a Rat Model of Parkinson\u2019s Disease. Mol Ther J Am Soc Gene Ther. 20:1315\u20131326. https:\/\/doi.org\/10.1038\/mt.2012.1","journal-title":"Mol Ther J Am Soc Gene Ther."},{"key":"2555_CR282","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.expneurol.2013.06.002","volume":"248","author":"X Ren","year":"2013","unstructured":"Ren X, Zhang T, Gong X, Hu G, Ding W, Wang X (2013) AAV2-Mediated Striatum Delivery of Human CDNF Prevents the Deterioration of Midbrain Dopamine Neurons in a 6-Hydroxydopamine Induced Parkinsonian Rat Model. Exp Neurol 248:148\u2013156. https:\/\/doi.org\/10.1016\/j.expneurol.2013.06.002","journal-title":"Exp Neurol"},{"key":"2555_CR283","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1006\/exnr.2002.8006","volume":"177","author":"B Georgievska","year":"2002","unstructured":"Georgievska B, Kirik D, Bj\u00f6rklund A (2002) Aberrant Sprouting and Downregulation of Tyrosine Hydroxylase in Lesioned Nigrostriatal Dopamine Neurons Induced by Long-Lasting Overexpression of Glial Cell Line Derived Neurotrophic Factor in the Striatum by Lentiviral Gene Transfer. Exp Neurol 177:461\u2013474. https:\/\/doi.org\/10.1006\/exnr.2002.8006","journal-title":"Exp Neurol"},{"key":"2555_CR284","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/brb3.117","volume":"3","author":"S B\u00e4ck","year":"2013","unstructured":"B\u00e4ck S, Per\u00e4nen J, Galli E, Pulkkila P, Lonka-Nevalaita L, Tamminen T, Voutilainen MH, Raasmaja A, Saarma M, M\u00e4nnist\u00f6 PT et al (2013) Gene Therapy with AAV2-CDNF Provides Functional Benefits in a Rat Model of Parkinson\u2019s Disease. Brain Behav 3:75\u201388. https:\/\/doi.org\/10.1002\/brb3.117","journal-title":"Brain Behav"},{"key":"2555_CR285","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.expneurol.2014.04.013","volume":"262","author":"CS Leblond","year":"2014","unstructured":"Leblond CS, Kaneb HM, Dion PA, Rouleau GA (2014) Dissection of Genetic Factors Associated with Amyotrophic Lateral Sclerosis. Exp Neurol 262:91\u2013101. https:\/\/doi.org\/10.1016\/j.expneurol.2014.04.013","journal-title":"Exp Neurol"},{"key":"2555_CR286","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S1474-4422(13)70061-9","volume":"12","author":"TM Miller","year":"2013","unstructured":"Miller TM, Pestronk A, David W, Rothstein J, Simpson E, Appel SH, Andres PL, Mahoney K, Allred P, Alexander K et al (2013) An Antisense Oligonucleotide against SOD1 Delivered Intrathecally for Patients with SOD1 Familial Amyotrophic Lateral Sclerosis: A Phase 1, Randomised, First-in-Man Study. Lancet Neurol 12:435\u2013442. https:\/\/doi.org\/10.1016\/S1474-4422(13)70061-9","journal-title":"Lancet Neurol"},{"key":"2555_CR287","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/nm0696-696","volume":"2","author":"P Aebischer","year":"1996","unstructured":"Aebischer P, Schluep M, D\u00e9glon N, Joseph J-M, Hirt L, Heyd B, Goddard M, Hammang JP, Zurn AD, Kato AC (1996) Intrathecal Delivery of CNTF Using Encapsulated Genetically Modifiedxenogeneic Cells in Amyotrophic Lateral Sclerosis Patients. Nat Med 2:696\u2013699","journal-title":"Nat Med"},{"key":"2555_CR288","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1038\/mt.2008.216","volume":"16","author":"BK Kaspar","year":"2008","unstructured":"Kaspar BK (2008) Mesenchymal Stem Cells as Trojan Horses for GDNF Delivery in ALS. Mol Ther 16:1905\u20131906","journal-title":"Mol Ther"},{"key":"2555_CR289","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1038\/mt.2008.197","volume":"16","author":"M Suzuki","year":"2008","unstructured":"Suzuki M, McHugh J, Tork C, Shelley B, Hayes A, Bellantuono I, Aebischer P, Svendsen CN (2008) Direct Muscle Delivery of GDNF with Human Mesenchymal Stem Cells Improves Motor Neuron Survival and Function in a Rat Model of Familial ALS. Mol Ther 16:2002\u20132010","journal-title":"Mol Ther"},{"key":"2555_CR290","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3727\/000000008783907053","volume":"17","author":"M Suzuki","year":"2008","unstructured":"Suzuki M, McHugh J, Tork C, Shelley B, Hayes A, Bellantuono I, Aebischer P, Svendsen CN (2008) Intramuscular Delivery of GDNF with Human Mesenchymal Stem Cells Protects Dying Motor Neurons and Prolongs Survival in a Rat Model of Familial ALS. Cell Transplant 17:482\u2013483","journal-title":"Cell Transplant"},{"key":"2555_CR291","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1089\/104303402753812458","volume":"13","author":"G Acsadi","year":"2002","unstructured":"Acsadi G, Anguelov RA, Yang H, Toth G, Thomas R, Jani A, Wang Y, Ianakova E, Mohammad S, Lewis RA (2002) Increased Survival and Function of SOD1 Mice after Glial Cell-Derived Neurotrophic Factor Gene Therapy. Hum Gene Ther 13:1047\u20131059","journal-title":"Hum Gene Ther"},{"key":"2555_CR292","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nm0497-429","volume":"3","author":"G Haase","year":"1997","unstructured":"Haase G, Kennel P, Pettmann B, Vigne E, Akli S, Revah F, Schmalbruch H, Kahn A (1997) Gene Therapy of Murine Motor Neuron Disease Using Adenoviral Vectors for Neurotrophic Factors. Nat Med 3:429\u2013436","journal-title":"Nat Med"},{"key":"2555_CR293","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.tins.2004.03.002","volume":"27","author":"S Boill\u00e9e","year":"2004","unstructured":"Boill\u00e9e S, Cleveland DW (2004) Gene Therapy for ALS Delivers. Trends Neurosci 27:235\u2013238","journal-title":"Trends Neurosci"},{"key":"2555_CR294","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/ana.20901","volume":"60","author":"DM Deshpande","year":"2006","unstructured":"Deshpande DM, Kim Y-S, Martinez T, Carmen J, Dike S, Shats I, Rubin LL, Drummond J, Krishnan C, Hoke A (2006) Recovery from Paralysis in Adult Rats Using Embryonic Stem Cells. Ann Neurol 60:32\u201344","journal-title":"Ann Neurol"},{"key":"2555_CR295","doi-asserted-by":"publisher","first-page":"7123","DOI":"10.1073\/pnas.0401103101","volume":"101","author":"JM Harper","year":"2004","unstructured":"Harper JM, Krishnan C, Darman JS, Deshpande DM, Peck S, Shats I, Backovic S, Rothstein JD, Kerr DA (2004) Axonal Growth of Embryonic Stem Cell-Derived Motoneurons in Vitro and in Motoneuron-Injured Adult Rats. Proc Natl Acad Sci 101:7123\u20137128","journal-title":"Proc Natl Acad Sci"},{"key":"2555_CR296","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.3727\/096368909X12483162197123","volume":"18","author":"R L\u00f3pez-Gonz\u00e1lez","year":"2009","unstructured":"L\u00f3pez-Gonz\u00e1lez R, Kunckles P, Velasco I (2009) Transient Recovery in a Rat Model of Familial Amyotrophic Lateral Sclerosis after Transplantation of Motor Neurons Derived from Mouse Embryonic Stem Cells. Cell Transplant 18:1171\u20131181","journal-title":"Cell Transplant"},{"key":"2555_CR297","doi-asserted-by":"publisher","first-page":"12409","DOI":"10.1523\/JNEUROSCI.1761-08.2008","volume":"28","author":"DC Yohn","year":"2008","unstructured":"Yohn DC, Miles GB, Rafuse VF, Brownstone RM (2008) Transplanted Mouse Embryonic Stem-Cell-Derived Motoneurons Form Functional Motor Units and Reduce Muscle Atrophy. J Neurosci 28:12409\u201312418","journal-title":"J Neurosci"},{"key":"2555_CR298","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s13311-011-0068-7","volume":"8","author":"G Gowing","year":"2011","unstructured":"Gowing G, Svendsen CN (2011) Stem Cell Transplantation for Motor Neuron Disease: Current Approaches and Future Perspectives. Neurotherapeutics 8:591\u2013606","journal-title":"Neurotherapeutics"},{"key":"2555_CR299","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/term.1972","volume":"11","author":"S Knippenberg","year":"2017","unstructured":"Knippenberg S, Rath KJ, B\u00f6selt S, Thau-Habermann N, Schwarz SC, Dengler R, Wegner F, Petri S (2017) Intraspinal Administration of Human Spinal Cord-Derived Neural Progenitor Cells in the G93A\u2013SOD1 Mouse Model of ALS Delays Symptom Progression, Prolongs Survival and Increases Expression of Endogenous Neurotrophic Factors. J Tissue Eng Regen Med 11:751\u2013764","journal-title":"J Tissue Eng Regen Med"},{"key":"2555_CR300","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.stemcr.2014.05.017","volume":"3","author":"T Kondo","year":"2014","unstructured":"Kondo T, Funayama M, Tsukita K, Hotta A, Yasuda A, Nori S, Kaneko S, Nakamura M, Takahashi R, Okano H (2014) Focal Transplantation of Human IPSC-Derived Glial-Rich Neural Progenitors Improves Lifespan of ALS Mice. Stem Cell Rep 3:242\u2013249","journal-title":"Stem Cell Rep"},{"key":"2555_CR301","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3858\/emm.2009.41.7.054","volume":"41","author":"S Park","year":"2009","unstructured":"Park S, Kim H-T, Yun S, Kim I-S, Lee J, Lee I-S, Park KI (2009) Growth Factor-Expressing Human Neural Progenitor Cell Grafts Protect Motor Neurons but Do Not Ameliorate Motor Performance and Survival in ALS Mice. Exp Mol Med 41:487\u2013500","journal-title":"Exp Mol Med"},{"key":"2555_CR302","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1164\/rccm.201206-1072OC","volume":"187","author":"NL Nichols","year":"2013","unstructured":"Nichols NL, Gowing G, Satriotomo I, Nashold LJ, Dale EA, Suzuki M, Avalos P, Mulcrone PL, McHugh J, Svendsen CN (2013) Intermittent Hypoxia and Stem Cell Implants Preserve Breathing Capacity in a Rodent Model of Amyotrophic Lateral Sclerosis. Am J Respir Crit Care Med 187:535\u2013542","journal-title":"Am J Respir Crit Care Med"},{"key":"2555_CR303","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/scrt421","volume":"5","author":"CM Lewis","year":"2014","unstructured":"Lewis CM, Suzuki M (2014) Therapeutic Applications of Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis. Stem Cell Res Ther 5:1\u201310","journal-title":"Stem Cell Res Ther"},{"key":"2555_CR304","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1001\/jamaneurol.2015.4321","volume":"73","author":"P Petrou","year":"2016","unstructured":"Petrou P, Gothelf Y, Argov Z, Gotkine M, Levy YS, Kassis I, Vaknin-Dembinsky A, Ben-Hur T, Offen D, Abramsky O (2016) Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients with Amyotrophic Lateral Sclerosis: Results of Phase 1\/2 and 2a Clinical Trials. JAMA Neurol 73:337\u2013344","journal-title":"JAMA Neurol"},{"key":"2555_CR305","doi-asserted-by":"publisher","first-page":"15587","DOI":"10.1523\/JNEUROSCI.2037-14.2014","volume":"34","author":"GM Thomsen","year":"2014","unstructured":"Thomsen GM, Gowing G, Latter J, Chen M, Vit J-P, Staggenborg K, Avalos P, Alkaslasi M, Ferraiuolo L, Likhite S et al (2014) Delayed Disease Onset and Extended Survival in the SOD1G93A Rat Model of Amyotrophic Lateral Sclerosis after Suppression of Mutant SOD1 in the Motor Cortex. J Neurosci Off J Soc Neurosci 34:15587\u201315600. https:\/\/doi.org\/10.1523\/JNEUROSCI.2037-14.2014","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"2555_CR306","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/mt.2013.239","volume":"22","author":"P Patel","year":"2014","unstructured":"Patel P, Kriz J, Gravel M, Soucy G, Bareil C, Gravel C, Julien J-P (2014) Adeno-Associated Virus-Mediated Delivery of a Recombinant Single-Chain Antibody against Misfolded Superoxide Dismutase for Treatment of Amyotrophic Lateral Sclerosis. Mol Ther J Am Soc Gene Ther. 22:498\u2013510. https:\/\/doi.org\/10.1038\/mt.2013.239","journal-title":"Mol Ther J Am Soc Gene Ther."},{"key":"2555_CR307","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1038\/mt.2010.206","volume":"18","author":"JC Dodge","year":"2010","unstructured":"Dodge JC, Treleaven CM, Fidler JA, Hester M, Haidet A, Handy C, Rao M, Eagle A, Matthews JC, Taksir TV et al (2010) AAV4-Mediated Expression of IGF-1 and VEGF within Cellular Components of the Ventricular System Improves Survival Outcome in Familial ALS Mice. Mol Ther J Am Soc Gene Ther. 18:2075\u20132084. https:\/\/doi.org\/10.1038\/mt.2010.206","journal-title":"Mol Ther J Am Soc Gene Ther."},{"key":"2555_CR308","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3109\/17482968.2011.574142","volume":"12","author":"MA Kliem","year":"2011","unstructured":"Kliem MA, Heeke BL, Franz CK, Radovitskiy I, Raore B, Barrow E, Snyder BR, Federici T, Kaye Spratt S, Boulis NM (2011) Intramuscular Administration of a VEGF Zinc Finger Transcription Factor Activator (VEGF-ZFP-TF) Improves Functional Outcomes in SOD1 Rats. Amyotroph Lateral Scler 12:331\u2013339. https:\/\/doi.org\/10.3109\/17482968.2011.574142","journal-title":"Amyotroph Lateral Scler"},{"key":"2555_CR309","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/mt.2010.271","volume":"19","author":"A Henriques","year":"2011","unstructured":"Henriques A, Pitzer C, Dittgen T, Klugmann M, Dupuis L, Schneider A (2011) CNS-Targeted Viral Delivery of G-CSF in an Animal Model for ALS: Improved Efficacy and Preservation of the Neuromuscular Unit. Mol Ther J Am Soc Gene Ther 19:284\u2013292. https:\/\/doi.org\/10.1038\/mt.2010.271","journal-title":"Mol Ther J Am Soc Gene Ther"},{"key":"2555_CR310","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/nn.3688","volume":"17","author":"JO Johnson","year":"2014","unstructured":"Johnson JO, Pioro EP, Boehringer A, Chia R, Feit H, Renton AE, Pliner HA, Abramzon Y, Marangi G, Winborn BJ et al (2014) Mutations in the Matrin 3 Gene Cause Familial Amyotrophic Lateral Sclerosis. Nat Neurosci 17:664\u2013666. https:\/\/doi.org\/10.1038\/nn.3688","journal-title":"Nat Neurosci"},{"key":"2555_CR311","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3109\/21678421.2016.1148170","volume":"17","author":"S Baxter","year":"2016","unstructured":"Baxter S, Reed H, Clarke Z, Judge S, Heron N, Mccarthy A, Langley J, Stanton A, Wells O, Squire G et al (2016) Evaluating a Novel Cervical Orthosis, the Sheffield Support Snood, in Patients with Amyotrophic Lateral Sclerosis\/Motor Neuron Disease with Neck Weakness. Amyotroph Lateral Scler Front Degener 17:436\u2013442. https:\/\/doi.org\/10.3109\/21678421.2016.1148170","journal-title":"Amyotroph Lateral Scler Front Degener"},{"key":"2555_CR312","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/s1474-4422(16)30399-4","volume":"16","author":"V Meininger","year":"2017","unstructured":"Meininger V, Genge A, van den Berg LH, Robberecht W, Ludolph A, Chio A, Kim SH, Leigh PN, Kiernan MC, Shefner JM et al (2017) Safety and Efficacy of Ozanezumab in Patients with Amyotrophic Lateral Sclerosis: A Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial. Lancet Neurol 16:208\u2013216. https:\/\/doi.org\/10.1016\/s1474-4422(16)30399-4","journal-title":"Lancet Neurol"},{"key":"2555_CR313","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1365-2990.2010.01124.x","volume":"37","author":"C Nicaise","year":"2011","unstructured":"Nicaise C, Mitrecic D, Pochet R (2011) Brain and Spinal Cord Affected by Amyotrophic Lateral Sclerosis Induce Differential Growth Factors Expression in Rat Mesenchymal and Neural Stem Cells. Neuropathol Appl Neurobiol 37:179\u2013188","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2555_CR314","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/nrneurol.2015.77","volume":"11","author":"I Faravelli","year":"2015","unstructured":"Faravelli I, Nizzardo M, Comi GP, Corti S (2015) Spinal Muscular Atrophy\u2014Recent Therapeutic Advances for an Old Challenge. Nat Rev Neurol 11:351\u2013359. https:\/\/doi.org\/10.1038\/nrneurol.2015.77","journal-title":"Nat Rev Neurol"},{"key":"2555_CR315","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1517\/14712598.2012.711306","volume":"12","author":"EM Donnelly","year":"2012","unstructured":"Donnelly EM, Boulis NM (2012) Update on Gene and Stem Cell Therapy Approaches for Spinal Muscular Atrophy. Expert Opin Biol Ther 12:1463\u20131471. https:\/\/doi.org\/10.1517\/14712598.2012.711306","journal-title":"Expert Opin Biol Ther"},{"key":"2555_CR316","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1093\/hmg\/ddq300","volume":"19","author":"AK Bevan","year":"2010","unstructured":"Bevan AK, Hutchinson KR, Foust KD, Braun L, McGovern VL, Schmelzer L, Ward JG, Petruska JC, Lucchesi PA, Burghes AHM et al (2010) Early Heart Failure in the SMNDelta7 Model of Spinal Muscular Atrophy and Correction by Postnatal ScAAV9-SMN Delivery. Hum Mol Genet 19:3895\u20133905. https:\/\/doi.org\/10.1093\/hmg\/ddq300","journal-title":"Hum Mol Genet"},{"key":"2555_CR317","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/ana.24332","volume":"77","author":"SI Duque","year":"2015","unstructured":"Duque SI, Arnold WD, Odermatt P, Li X, Porensky PN, Schmelzer L, Meyer K, Kolb SJ, Sch\u00fcmperli D, Kaspar BK et al (2015) A Large Animal Model of Spinal Muscular Atrophy and Correction of Phenotype. Ann Neurol 77:399\u2013414. https:\/\/doi.org\/10.1002\/ana.24332","journal-title":"Ann Neurol"},{"key":"2555_CR318","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.3390\/ijms22084249","volume":"22","author":"R Afonso-Reis","year":"2021","unstructured":"Afonso-Reis R, Afonso IT, N\u00f3brega C (2021) Current Status of Gene Therapy Research in Polyglutamine Spinocerebellar Ataxias. Int J Mol Sci 22:4249","journal-title":"Int J Mol Sci"},{"key":"2555_CR319","doi-asserted-by":"publisher","first-page":"291","DOI":"10.4103\/0366-6999.150087","volume":"128","author":"S Tan","year":"2015","unstructured":"Tan S, Wang R-H, Niu H-X, Shi C-H, Mao C-Y, Zhang R, Song B, Sun S-L, Liu X-J, Hou H-M (2015) Nerve Growth Factor for the Treatment of Spinocerebellar Ataxia Type 3: An Open-Label Study. Chin Med J (Engl) 128:291","journal-title":"Chin Med J (Engl)"},{"key":"2555_CR320","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.3390\/ijms21093063","volume":"21","author":"Y-S Chen","year":"2020","unstructured":"Chen Y-S, Hong Z-X, Lin S-Z, Harn H-J (2020) Identifying Therapeutic Targets for Spinocerebellar Ataxia Type 3\/Machado\u2013Joseph Disease through Integration of Pathological Biomarkers and Therapeutic Strategies. Int J Mol Sci 21:3063","journal-title":"Int J Mol Sci"},{"key":"2555_CR321","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/j.0013-9580.2005.66104.x","volume":"46","author":"RS Fisher","year":"2005","unstructured":"Fisher RS, van Boas WE, Blume W, Elger C, Genton P, Lee P Jr, Engel J (2005) Epileptic Seizures and Epilepsy: Definitions Proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 46:470\u2013472. https:\/\/doi.org\/10.1111\/j.0013-9580.2005.66104.x","journal-title":"Epilepsia"},{"key":"2555_CR322","doi-asserted-by":"publisher","first-page":"11342","DOI":"10.1523\/JNEUROSCI.3329-06.2006","volume":"26","author":"YH Raol","year":"2006","unstructured":"Raol YH, Lund IV, Bandyopadhyay S, Zhang G, Roberts DS, Wolfe JH, Russek SJ, Brooks-Kayal AR (2006) Enhancing GABA<Sub>A<\/Sub> Receptor \u03911 Subunit Levels in Hippocampal Dentate Gyrus Inhibits Epilepsy Development in an Animal Model of Temporal Lobe Epilepsy. J. Neurosci. 26:11342\u201311346. https:\/\/doi.org\/10.1523\/JNEUROSCI.3329-06.2006","journal-title":"J. Neurosci."},{"key":"2555_CR323","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1523\/JNEUROSCI.4056-03.2004","volume":"24","author":"C Richichi","year":"2004","unstructured":"Richichi C, Lin E-JD, Stefanin D, Colella D, Ravizza T, Grignaschi G, Veglianese P, Sperk G, During MJ, Vezzani A (2004) Anticonvulsant and Antiepileptogenic Effects Mediated by Adeno-Associated Virus Vector Neuropeptide Y Expression in the Rat Hippocampus. J. Neurosci. 24:3051\u20133059. https:\/\/doi.org\/10.1523\/JNEUROSCI.4056-03.2004","journal-title":"J. Neurosci."},{"key":"2555_CR324","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1038\/sj.gt.3303013","volume":"14","author":"S Foti","year":"2007","unstructured":"Foti S, Haberman RP, Samulski RJ, McCown TJ (2007) Adeno-Associated Virus-Mediated Expression and Constitutive Secretion of NPY or NPY13-36 Suppresses Seizure Activity in Vivo. Gene Ther 14:1534\u20131536. https:\/\/doi.org\/10.1038\/sj.gt.3303013","journal-title":"Gene Ther"},{"key":"2555_CR325","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1093\/brain\/awn079","volume":"131","author":"F No\u00e8","year":"2008","unstructured":"No\u00e8 F, Pool A-H, Nissinen J, Gobbi M, Bland R, Rizzi M, Balducci C, Ferraguti F, Sperk G, During MJ et al (2008) Neuropeptide Y Gene Therapy Decreases Chronic Spontaneous Seizures in a Rat Model of Temporal Lobe Epilepsy. Brain 131:1506\u20131515. https:\/\/doi.org\/10.1093\/brain\/awn079","journal-title":"Brain"},{"key":"2555_CR326","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.expneurol.2008.10.015","volume":"215","author":"AT S\u00f8rensen","year":"2009","unstructured":"S\u00f8rensen AT, Nikitidou L, Ledri M, Lin E-JD, During MJ, Kanter-Schlifke I, Kokaia M (2009) Hippocampal NPY Gene Transfer Attenuates Seizures without Affecting Epilepsy-Induced Impairment of LTP. Exp Neurol 215:328\u2013333. https:\/\/doi.org\/10.1016\/j.expneurol.2008.10.015","journal-title":"Exp Neurol"},{"key":"2555_CR327","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/gt.2010.23","volume":"17","author":"F Noe","year":"2010","unstructured":"Noe F, Vaghi V, Balducci C, Fitzsimons H, Bland R, Zardoni D, Sperk G, Carli M, During MJ, Vezzani A (2010) Anticonvulsant Effects and Behavioural Outcomes of RAAV Serotype 1 Vector-Mediated Neuropeptide Y Overexpression in Rat Hippocampus. Gene Ther 17:643\u2013652. https:\/\/doi.org\/10.1038\/gt.2010.23","journal-title":"Gene Ther"},{"key":"2555_CR328","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1093\/brain\/awq219","volume":"133","author":"DPD Woldbye","year":"2010","unstructured":"Woldbye DPD, \u00c4ngehagen M, G\u00f8tzsche CR, Elbr\u00f8nd-Bek H, S\u00f8rensen AT, Christiansen SH, Olesen MV, Nikitidou L, Hansen TVO, Kanter-Schlifke I et al (2010) Adeno-Associated Viral Vector-Induced Overexpression of Neuropeptide Y Y2 Receptors in the Hippocampus Suppresses Seizures. Brain 133:2778\u20132788. https:\/\/doi.org\/10.1093\/brain\/awq219","journal-title":"Brain"},{"key":"2555_CR329","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/s41591-018-0103-x","volume":"24","author":"A Lieb","year":"2018","unstructured":"Lieb A, Qiu Y, Dixon CL, Heller JP, Walker MC, Schorge S, Kullmann DM (2018) Biochemical Autoregulatory Gene Therapy for Focal Epilepsy. Nat Med 24:1324\u20131329","journal-title":"Nat Med"},{"key":"2555_CR330","unstructured":"(2020) University College, London Phase I\/IIa, First-in-Human, Open-Label, Single-Site Trial of In-Vivo Lentiviral Engineered Potassium (K+) Channel (EKC) Gene Therapy for Refractory Epilepsy; clinicaltrials.gov"},{"key":"2555_CR331","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"ME MacDonald","year":"1993","unstructured":"MacDonald ME, Ambrose CM, Duyao MP, Myers RH, Lin C, Srinidhi L, Barnes G, Taylor SA, James M, Groot N et al (1993) A Novel Gene Containing a Trinucleotide Repeat That Is Expanded and Unstable on Huntington\u2019s Disease Chromosomes. Cell 72:971\u2013983. https:\/\/doi.org\/10.1016\/0092-8674(93)90585-E","journal-title":"Cell"},{"key":"2555_CR332","doi-asserted-by":"publisher","first-page":"5037","DOI":"10.1073\/pnas.93.10.5037","volume":"93","author":"J Bao","year":"1996","unstructured":"Bao J, Sharp AH, Wagster MV, Becher M, Schilling G, Ross CA, Dawson VL, Dawson TM (1996) Expansion of Polyglutamine Repeat in Huntingtin Leads to Abnormal Protein Interactions Involving Calmodulin. Proc Natl Acad Sci U S A 93:5037\u20135042. https:\/\/doi.org\/10.1073\/pnas.93.10.5037","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2555_CR333","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1089\/10430349950016393","volume":"10","author":"A-P Bemelmans","year":"1999","unstructured":"Bemelmans A-P, Horellou P, Pradier L, Brunet I, Colin P, Mallet J (1999) Brain-Derived Neurotrophic Factor-Mediated Protection of Striatal Neurons in an Excitotoxic Rat Model of Huntington\u2019s Disease, as Demonstrated by Adenoviral Gene Transfer. Hum Gene Ther 10:2987\u20132997. https:\/\/doi.org\/10.1089\/10430349950016393","journal-title":"Hum Gene Ther"},{"key":"2555_CR334","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2217\/rme.15.25","volume":"10","author":"KD Fink","year":"2015","unstructured":"Fink KD, Deng P, Torrest A, Stewart H, Pollock K, Gruenloh W, Annett G, Tempkin T, Wheelock V, Nolta JA (2015) Developing Stem Cell Therapies for Juvenile and Adult-Onset Huntington\u2019s Disease. Regen Med 10:623\u2013646","journal-title":"Regen Med"},{"key":"2555_CR335","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/bpa.12432","volume":"26","author":"M Puigdell\u00edvol","year":"2016","unstructured":"Puigdell\u00edvol M, Saavedra A, P\u00e9rez-Navarro E (2016) Cognitive Dysfunction in H Untington\u2019s Disease: Mechanisms and Therapeutic Strategies beyond BDNF. Brain Pathol 26:752\u2013771","journal-title":"Brain Pathol"},{"key":"2555_CR336","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/gt.2017.14","volume":"24","author":"L Samaranch","year":"2017","unstructured":"Samaranch L, Blits B, San Sebastian W, Hadaczek P, Bringas J, Sudhakar V, Macayan M, Pivirotto PJ, Petry H, Bankiewicz KS (2017) MR-Guided Parenchymal Delivery of Adeno-Associated Viral Vector Serotype 5 in Non-Human Primate Brain. Gene Ther 24:253\u2013261","journal-title":"Gene Ther"},{"key":"2555_CR337","doi-asserted-by":"publisher","first-page":"13589","DOI":"10.1523\/JNEUROSCI.4286-09.2009","volume":"29","author":"AL Southwell","year":"2009","unstructured":"Southwell AL, Ko J, Patterson PH (2009) Intrabody Gene Therapy Ameliorates Motor, Cognitive, and Neuropathological Symptoms in Multiple Mouse Models of Huntington\u2019s Disease. J Neurosci Off J Soc Neurosci 29:13589\u201313602. https:\/\/doi.org\/10.1523\/JNEUROSCI.4286-09.2009","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"2555_CR338","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1046\/j.1471-4159.2003.01756.x","volume":"85","author":"H Zhao","year":"2003","unstructured":"Zhao H, Yenari MA, Cheng D, Sapolsky RM, Steinberg GK (2003) Bcl-2 Overexpression Protects against Neuron Loss within the Ischemic Margin Following Experimental Stroke and Inhibits Cytochrome c Translocation and Caspase-3 Activity. J Neurochem 85:1026\u20131036. https:\/\/doi.org\/10.1046\/j.1471-4159.2003.01756.x","journal-title":"J Neurochem"},{"key":"2555_CR339","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.3727\/096368912X657323","volume":"22","author":"D-J Chang","year":"2013","unstructured":"Chang D-J, Lee N, Choi C, Jeon I, Oh S-H, Shin DA, Hwang T-S, Lee HJ, Kim SU, Moon H (2013) Therapeutic Effect of BDNF-Overexpressing Human Neural Stem Cells (HB1. F3. BDNF) in a Rodent Model of Middle Cerebral Artery Occlusion. Cell Transplant. 22:1441\u20131452","journal-title":"Cell Transplant."},{"key":"2555_CR340","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2009.05.100","volume":"1284","author":"B Chen","year":"2009","unstructured":"Chen B, Gao X-Q, Yang C-X, Tan S-K, Sun Z-L, Yan N-H, Pang Y-G, Yuan M, Chen G-J, Xu G-T (2009) Neuroprotective Effect of Grafting GDNF Gene-Modified Neural Stem Cells on Cerebral Ischemia in Rats. Brain Res 1284:1\u201311","journal-title":"Brain Res"},{"key":"2555_CR341","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/jnr.21056","volume":"84","author":"Y Horita","year":"2006","unstructured":"Horita Y, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD (2006) Intravenous Administration of Glial Cell Line-Derived Neurotrophic Factor Gene-Modified Human Mesenchymal Stem Cells Protects against Injury in a Cerebral Ischemia Model in the Adult Rat. J Neurosci Res 84:1495\u20131504","journal-title":"J Neurosci Res"},{"key":"2555_CR342","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ymthe.2004.09.020","volume":"11","author":"K Kurozumi","year":"2005","unstructured":"Kurozumi K, Nakamura K, Tamiya T, Kawano Y, Ishii K, Kobune M, Hirai S, Uchida H, Sasaki K, Ito Y (2005) Mesenchymal Stem Cells That Produce Neurotrophic Factors Reduce Ischemic Damage in the Rat Middle Cerebral Artery Occlusion Model. Mol Ther 11:96\u2013104","journal-title":"Mol Ther"},{"key":"2555_CR343","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1227\/01.NEU.0000290907.30814.42","volume":"61","author":"Y Miki","year":"2007","unstructured":"Miki Y, Nonoguchi N, Ikeda N, Coffin RS, Kuroiwa T, Miyatake S-I (2007) Vascular Endothelial Growth Factor Gene-Transferred Bone Marrow Stromal Cells Engineered with a Herpes Simplex Virus Type 1 Vector Can Improve Neurological Deficits and Reduce Infarction Volume in Rat Brain Ischemia. Neurosurgery 61:586\u2013595","journal-title":"Neurosurgery"},{"key":"2555_CR344","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1093\/brain\/awr094","volume":"134","author":"RH Andres","year":"2011","unstructured":"Andres RH, Horie N, Slikker W, Keren-Gill H, Zhan K, Sun G, Manley NC, Pereira MP, Sheikh LA, McMillan EL (2011) Human Neural Stem Cells Enhance Structural Plasticity and Axonal Transport in the Ischaemic Brain. Brain 134:1777\u20131789","journal-title":"Brain"},{"key":"2555_CR345","doi-asserted-by":"publisher","first-page":"8396","DOI":"10.1155\/2015\/839638","volume":"2015","author":"A Popa-Wagner","year":"2015","unstructured":"Popa-Wagner A, Filfan M, Uzoni A, Pourgolafshan P, Buga A-M (2015) Poststroke Cell Therapy of the Aged Brain. Neural Plast. 2015:8396","journal-title":"Neural Plast."},{"key":"2555_CR346","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.stem.2015.06.007","volume":"17","author":"A Trounson","year":"2015","unstructured":"Trounson A, McDonald C (2015) Stem Cell Therapies in Clinical Trials: Progress and Challenges. Cell Stem Cell 17:11\u201322","journal-title":"Cell Stem Cell"},{"key":"2555_CR347","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0169-328X(95)00315-J","volume":"37","author":"T Nimura","year":"1996","unstructured":"Nimura T, Weinstein PR, Massa SM, Panter S, Sharp FR (1996) Heme Oxygenase-1 (HO-1) Protein Induction in Rat Brain Following Focal Ischemia. Mol Brain Res 37:201\u2013208. https:\/\/doi.org\/10.1016\/0169-328X(95)00315-J","journal-title":"Mol Brain Res"},{"key":"2555_CR348","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1161\/01.str.0000091268.25816.19","volume":"34","author":"B Hoehn","year":"2003","unstructured":"Hoehn B, Yenari MA, Sapolsky RM, Steinberg GK (2003) Glutathione Peroxidase Overexpression Inhibits Cytochrome C Release and Proapoptotic Mediators to Protect Neurons from Experimental Stroke. Stroke 34:2489\u20132494. https:\/\/doi.org\/10.1161\/01.str.0000091268.25816.19","journal-title":"Stroke"},{"key":"2555_CR349","first-page":"1","volume":"5","author":"J Wang","year":"2015","unstructured":"Wang J, Xia J, Zhang F, Shi Y, Wu Y, Pu H, Liou AK, Leak RK, Yu X, Chen L (2015) Galectin-1-Secreting Neural Stem Cells Elicit Long-Term Neuroprotection against Ischemic Brain Injury. Sci Rep 5:1\u201310","journal-title":"Sci Rep"},{"key":"2555_CR350","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1161\/STROKEAHA.112.656900","volume":"43","author":"H Sakata","year":"2012","unstructured":"Sakata H, Niizuma K, Wakai T, Narasimhan P, Maier CM, Chan PH (2012) Neural Stem Cells Genetically Modified to Overexpress Cu\/Zn-Superoxide Dismutase Enhance Amelioration of Ischemic Stroke in Mice. Stroke 43:2423\u20132429","journal-title":"Stroke"},{"key":"2555_CR351","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1111\/j.1460-9568.2004.03184.x","volume":"19","author":"JE Davies","year":"2004","unstructured":"Davies JE, Tang X, Denning JW, Archibald SJ, Davies SJA (2004) Decorin Suppresses Neurocan, Brevican, Phosphacan and NG2 Expression and Promotes Axon Growth across Adult Rat Spinal Cord Injuries. Eur J Neurosci 19:1226\u20131242. https:\/\/doi.org\/10.1111\/j.1460-9568.2004.03184.x","journal-title":"Eur J Neurosci"},{"key":"2555_CR352","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/jnr.10760","volume":"74","author":"J Tokumine","year":"2003","unstructured":"Tokumine J, Kakinohana O, Cizkova D, Smith DW, Marsala M (2003) Changes in Spinal GDNF, BDNF, and NT-3 Expression after Transient Spinal Cord Ischemia in the Rat. J Neurosci Res 74:552\u2013561. https:\/\/doi.org\/10.1002\/jnr.10760","journal-title":"J Neurosci Res"},{"key":"2555_CR353","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1093\/brain\/awm155","volume":"130","author":"F Papastefanaki","year":"2007","unstructured":"Papastefanaki F, Chen J, Lavdas AA, Thomaidou D, Schachner M, Matsas R (2007) Grafts of Schwann Cells Engineered to Express PSA-NCAM Promote Functional Recovery after Spinal Cord Injury. Brain 130:2159\u20132174. https:\/\/doi.org\/10.1093\/brain\/awm155","journal-title":"Brain"},{"key":"2555_CR354","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1002\/jnr.22322","volume":"88","author":"J Yamane","year":"2010","unstructured":"Yamane J, Nakamura M, Iwanami A, Sakaguchi M, Katoh H, Yamada M, Momoshima S, Miyao S, Ishii K, Tamaoki N et al (2010) Transplantation of Galectin-1-Expressing Human Neural Stem Cells into the Injured Spinal Cord of Adult Common Marmosets. J Neurosci Res 88:1394\u20131405. https:\/\/doi.org\/10.1002\/jnr.22322","journal-title":"J Neurosci Res"},{"key":"2555_CR355","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.expneurol.2008.06.012","volume":"214","author":"RE White","year":"2008","unstructured":"White RE, Yin FQ, Jakeman LB (2008) TGF-Alpha Increases Astrocyte Invasion and Promotes Axonal Growth into the Lesion Following Spinal Cord Injury in Mice. Exp Neurol 214:10\u201324. https:\/\/doi.org\/10.1016\/j.expneurol.2008.06.012","journal-title":"Exp Neurol"},{"key":"2555_CR356","doi-asserted-by":"publisher","first-page":"4447","DOI":"10.1016\/j.biomaterials.2010.02.018","volume":"31","author":"VR King","year":"2010","unstructured":"King VR, Alovskaya A, Wei DYT, Brown RA, Priestley J (2010) V The Use of Injectable Forms of Fibrin and Fibronectin to Support Axonal Ingrowth after Spinal Cord Injury. Biomaterials 31:4447\u20134456. https:\/\/doi.org\/10.1016\/j.biomaterials.2010.02.018","journal-title":"Biomaterials"},{"key":"2555_CR357","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.bbrc.2007.04.049","volume":"357","author":"H Cheng","year":"2007","unstructured":"Cheng H, Huang Y-C, Chang P-T, Huang Y-Y (2007) Laminin-Incorporated Nerve Conduits Made by Plasma Treatment for Repairing Spinal Cord Injury. Biochem Biophys Res Commun 357:938\u2013944. https:\/\/doi.org\/10.1016\/j.bbrc.2007.04.049","journal-title":"Biochem Biophys Res Commun"},{"key":"2555_CR358","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1083\/jcb.94.3.574","volume":"94","author":"AD Lander","year":"1982","unstructured":"Lander AD, Fujii DK, Gospodarowicz D, Reichardt LF (1982) Characterization of a Factor That Promotes Neurite Outgrowth: Evidence Linking Activity to a Heparan Sulfate Proteoglycan. J Cell Biol 94:574\u2013585. https:\/\/doi.org\/10.1083\/jcb.94.3.574","journal-title":"J Cell Biol"},{"key":"2555_CR359","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/glia.20177","volume":"51","author":"BJ Kerr","year":"2005","unstructured":"Kerr BJ, Patterson PH (2005) Leukemia Inhibitory Factor Promotes Oligodendrocyte Survival after Spinal Cord Injury. Glia 51:73\u201379. https:\/\/doi.org\/10.1002\/glia.20177","journal-title":"Glia"},{"key":"2555_CR360","doi-asserted-by":"publisher","first-page":"3752","DOI":"10.1523\/JNEUROSCI.0406-04.2004","volume":"24","author":"TB Jones","year":"2004","unstructured":"Jones TB, Ankeny DP, Guan Z, McGaughy V, Fisher LC, Basso DM, Popovich PG (2004) Passive or Active Immunization with Myelin Basic Protein Impairs Neurological Function and Exacerbates Neuropathology after Spinal Cord Injury in Rats. J Neurosci Off J Soc Neurosci 24:3752\u20133761. https:\/\/doi.org\/10.1523\/JNEUROSCI.0406-04.2004","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"2555_CR361","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1089\/neu.2008.0586","volume":"25","author":"KE Saatman","year":"2008","unstructured":"Saatman KE, Duhaime A-C, Bullock R, Maas AI, Valadka A, Manley GT (2008) Classification of Traumatic Brain Injury for Targeted Therapies. J Neurotrauma 25:719\u2013738","journal-title":"J Neurotrauma"},{"key":"2555_CR362","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2016.84","volume":"2","author":"K Blennow","year":"2016","unstructured":"Blennow K, Brody DL, Kochanek PM, Levin H, McKee A, Ribbers GM, Yaffe K, Zetterberg H (2016) Traumatic Brain Injuries. Nat Rev Dis Primer 2:1\u201319","journal-title":"Nat Rev Dis Primer"},{"key":"2555_CR363","doi-asserted-by":"publisher","first-page":"2002155","DOI":"10.1002\/advs.202002155","volume":"7","author":"L Feng","year":"2020","unstructured":"Feng L, Chao J, Tian E, Li L, Ye P, Zhang M, Chen X, Cui Q, Sun G, Zhou T (2020) Cell-Based Therapy for Canavan Disease Using Human IPSC-Derived NPCs and OPCs. Adv Sci 7:2002155","journal-title":"Adv Sci"},{"key":"2555_CR364","doi-asserted-by":"publisher","first-page":"e12836","DOI":"10.15252\/emmm.202012836","volume":"13","author":"G Parenti","year":"2021","unstructured":"Parenti G, Medina DL, Ballabio A (2021) The Rapidly Evolving View of Lysosomal Storage Diseases. EMBO Mol. Med. 13:e12836","journal-title":"EMBO Mol. Med."},{"key":"2555_CR365","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/j.bbamcr.2006.07.010","volume":"1763","author":"J Berger","year":"2006","unstructured":"Berger J, G\u00e4rtner J (2006) X-Linked Adrenoleukodystrophy: Clinical, Biochemical and Pathogenetic Aspects. Biochim Biophys Acta BBA-Mol Cell Res 1763:1721\u20131732","journal-title":"Biochim Biophys Acta BBA-Mol Cell Res"},{"key":"2555_CR366","doi-asserted-by":"publisher","first-page":"R42","DOI":"10.1093\/hmg\/ddr142","volume":"20","author":"A Biffi","year":"2011","unstructured":"Biffi A, Aubourg P, Cartier N (2011) Gene Therapy for Leukodystrophies. Hum Mol Genet 20:R42\u2013R53","journal-title":"Hum Mol Genet"},{"key":"2555_CR367","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.biochi.2013.11.023","volume":"98","author":"J Berger","year":"2014","unstructured":"Berger J, Forss-Petter S, Eichler FS (2014) Pathophysiology of X-Linked Adrenoleukodystrophy. Biochimie 98:135\u2013142","journal-title":"Biochimie"},{"key":"2555_CR368","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1111\/j.1750-3639.2010.00393.x","volume":"20","author":"J Berger","year":"2010","unstructured":"Berger J, Pujol A, Aubourg P, Forss-Petter S (2010) Current and Future Pharmacological Treatment Strategies in X-Linked Adrenoleukodystrophy. Brain Pathol 20:845\u2013856","journal-title":"Brain Pathol"},{"key":"2555_CR369","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.pedneo.2011.08.002","volume":"52","author":"S-M Weng","year":"2011","unstructured":"Weng S-M, Bailey ME, Cobb SR (2011) Rett Syndrome: From Bed to Bench. Pediatr Neonatol 52:309\u2013316","journal-title":"Pediatr Neonatol"},{"key":"2555_CR370","doi-asserted-by":"publisher","first-page":"9941","DOI":"10.1073\/pnas.1311685111","volume":"111","author":"J Castro","year":"2014","unstructured":"Castro J, Garcia RI, Kwok S, Banerjee A, Petravicz J, Woodson J, Mellios N, Tropea D, Sur M (2014) Functional Recovery with Recombinant Human IGF1 Treatment in a Mouse Model of Rett Syndrome. Proc Natl Acad Sci 111:9941\u20139946","journal-title":"Proc Natl Acad Sci"},{"key":"2555_CR371","unstructured":"Subramaniam, V. AVXS-201 - Rett Syndrome News."},{"key":"2555_CR372","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.3390\/cells9071698","volume":"9","author":"S Paul","year":"2020","unstructured":"Paul S, Bravo V\u00e1zquez LA, P\u00e9rez Uribe S, Roxana Reyes-P\u00e9rez P, Sharma A (2020) Current Status of MicroRNA-Based Therapeutic Approaches in Neurodegenerative Disorders. Cells 9:1698","journal-title":"Cells"},{"key":"2555_CR373","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3389\/fnins.2020.579062","volume":"14","author":"F Duarte","year":"2020","unstructured":"Duarte F, D\u00e9glon N (2020) Genome Editing for CNS Disorders. Front Neurosci 14:1039","journal-title":"Front Neurosci"},{"key":"2555_CR374","doi-asserted-by":"publisher","first-page":"118165","DOI":"10.1016\/j.lfs.2020.118165","volume":"259","author":"A Karimian","year":"2020","unstructured":"Karimian A, Gorjizadeh N, Alemi F, Asemi Z, Azizian K, Soleimanpour J, Malakouti F, Targhazeh N, Majidinia M, Yousefi B (2020) CRISPR\/Cas9 Novel Therapeutic Road for the Treatment of Neurodegenerative Diseases. Life Sci. 259:118165","journal-title":"Life Sci."},{"key":"2555_CR375","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41593-019-0352-0","volume":"22","author":"H Park","year":"2019","unstructured":"Park H, Oh J, Shim G, Cho B, Chang Y, Kim S, Baek S, Kim H, Shin J, Choi H (2019) In Vivo Neuronal Gene Editing via CRISPR\u2013Cas9 Amphiphilic Nanocomplexes Alleviates Deficits in Mouse Models of Alzheimer\u2019s Disease. Nat Neurosci 22:524\u2013528","journal-title":"Nat Neurosci"},{"key":"2555_CR376","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nature09325","volume":"467","author":"G He","year":"2010","unstructured":"He G, Luo W, Li P, Remmers C, Netzer WJ, Hendrick J, Bettayeb K, Flajolet M, Gorelick F, Wennogle LP (2010) Gamma-Secretase Activating Protein Is a Therapeutic Target for Alzheimer\u2019s Disease. Nature 467:95\u201398","journal-title":"Nature"},{"key":"2555_CR377","doi-asserted-by":"publisher","first-page":"6385","DOI":"10.1073\/pnas.1820160116","volume":"116","author":"E Wong","year":"2019","unstructured":"Wong E, Liao GP, Chang JC, Xu P, Li Y-M, Greengard P (2019) GSAP Modulates \u03b3-Secretase Specificity by Inducing Conformational Change in PS1. Proc Natl Acad Sci 116:6385\u20136390","journal-title":"Proc Natl Acad Sci"},{"key":"2555_CR378","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.omtn.2018.03.007","volume":"11","author":"B Gy\u00f6rgy","year":"2018","unstructured":"Gy\u00f6rgy B, L\u00f6\u00f6v C, Zaborowski MP, Takeda S, Kleinstiver BP, Commins C, Kastanenka K, Mu D, Volak A, Giedraitis V (2018) CRISPR\/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer\u2019s Disease. Mol Ther-Nucleic Acids 11:429\u2013440","journal-title":"Mol Ther-Nucleic Acids"},{"key":"2555_CR379","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-04238-0","volume":"9","author":"K Nagata","year":"2018","unstructured":"Nagata K, Takahashi M, Matsuba Y, Okuyama-Uchimura F, Sato K, Hashimoto S, Saito T, Saido TC (2018) Generation of App Knock-in Mice Reveals Deletion Mutations Protective against Alzheimer\u2019s Disease-like Pathology. Nat Commun 9:1\u20137","journal-title":"Nat Commun"},{"key":"2555_CR380","doi-asserted-by":"publisher","first-page":"101349","DOI":"10.1016\/j.scr.2018.11.010","volume":"34","author":"B Schmid","year":"2019","unstructured":"Schmid B, Prehn KR, Nimsanor N, Garcia BIA, Poulsen U, J\u00f8rring I, Rasmussen MA, Clausen C, Mau-Holzmann UA, Ramakrishna S (2019) Generation of a Set of Isogenic, Gene-Edited IPSC Lines Homozygous for All Main APOE Variants and an APOE Knock-out Line. Stem Cell Res. 34:101349","journal-title":"Stem Cell Res."},{"key":"2555_CR381","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/ana.25455","volume":"85","author":"AR Wadhwani","year":"2019","unstructured":"Wadhwani AR, Affaneh A, Van Gulden S, Kessler JA (2019) Neuronal Apolipoprotein E4 Increases Cell Death and Phosphorylated Tau Release in Alzheimer Disease. Ann Neurol 85:726\u2013739","journal-title":"Ann Neurol"},{"key":"2555_CR382","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s12035-018-1068-y","volume":"56","author":"SP Raikwar","year":"2019","unstructured":"Raikwar SP, Thangavel R, Dubova I, Selvakumar GP, Ahmed ME, Kempuraj D, Zaheer SA, Iyer SS, Zaheer A (2019) Targeted Gene Editing of Glia Maturation Factor in Microglia: A Novel Alzheimer\u2019s Disease Therapeutic Target. Mol Neurobiol 56:378\u2013393","journal-title":"Mol Neurobiol"},{"key":"2555_CR383","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nature17939","volume":"533","author":"F Soldner","year":"2016","unstructured":"Soldner F, Stelzer Y, Shivalila CS, Abraham BJ, Latourelle JC, Barrasa MI, Goldmann J, Myers RH, Young RA, Jaenisch R (2016) Parkinson-Associated Risk Variant in Distal Enhancer of \u03b1-Synuclein Modulates Target Gene Expression. Nature 533:95\u201399","journal-title":"Nature"},{"key":"2555_CR384","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.scr.2017.08.013","volume":"24","author":"X Qing","year":"2017","unstructured":"Qing X, Walter J, Jarazo J, Arias-Fuenzalida J, Hillje A-L, Schwamborn JC (2017) CRISPR\/Cas9 and PiggyBac-Mediated Footprint-Free LRRK2-G2019S Knock-in Reveals Neuronal Complexity Phenotypes and \u03b1-Synuclein Modulation in Dopaminergic Neurons. Stem Cell Res 24:44\u201350","journal-title":"Stem Cell Res"},{"key":"2555_CR385","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/toxsci\/kfz049","volume":"169","author":"C Song","year":"2019","unstructured":"Song C, Charli A, Luo J, Riaz Z, Jin H, Anantharam V, Kanthasamy A, Kanthasamy AG (2019) Mechanistic Interplay between Autophagy and Apoptotic Signaling in Endosulfan-Induced Dopaminergic Neurotoxicity: Relevance to the Adverse Outcome Pathway in Pesticide Neurotoxicity. Toxicol Sci 169:333\u2013352","journal-title":"Toxicol Sci"},{"key":"2555_CR386","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms12932","volume":"7","author":"R Gordon","year":"2016","unstructured":"Gordon R, Neal ML, Luo J, Langley MR, Harischandra DS, Panicker N, Charli A, Jin H, Anantharam V, Woodruff TM (2016) Prokineticin-2 Upregulation during Neuronal Injury Mediates a Compensatory Protective Response against Dopaminergic Neuronal Degeneration. Nat Commun 7:1\u201318","journal-title":"Nat Commun"},{"key":"2555_CR387","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/ejn.14286","volume":"49","author":"Y Chen","year":"2019","unstructured":"Chen Y, Dolt KS, Kriek M, Baker T, Downey P, Drummond NJ, Canham MA, Natalwala A, Rosser S, Kunath T (2019) Engineering Synucleinopathy-Resistant Human Dopaminergic Neurons by CRISPR-Mediated Deletion of the SNCA Gene. Eur J Neurosci 49:510\u2013524","journal-title":"Eur J Neurosci"},{"key":"2555_CR388","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s11481-019-09833-6","volume":"14","author":"GP Selvakumar","year":"2019","unstructured":"Selvakumar GP, Ahmed ME, Raikwar SP, Thangavel R, Kempuraj D, Dubova I, Saeed D, Zahoor H, Premkumar K, Zaheer S (2019) CRISPR\/Cas9 Editing of Glia Maturation Factor Regulates Mitochondrial Dynamics by Attenuation of the NRF2\/HO-1 Dependent Ferritin Activation in Glial Cells. J Neuroimmune Pharmacol 14:537\u2013550","journal-title":"J Neuroimmune Pharmacol"},{"key":"2555_CR389","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/B978-0-12-801893-4.00001-8","volume":"144","author":"MA Nance","year":"2017","unstructured":"Nance MA (2017) Genetics of Huntington Disease. Handb Clin Neurol 144:3\u201314","journal-title":"Handb Clin Neurol"},{"key":"2555_CR390","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S1474-4422(17)30280-6","volume":"16","author":"EJ Wild","year":"2017","unstructured":"Wild EJ, Tabrizi SJ (2017) Therapies Targeting DNA and RNA in Huntington\u2019s Disease. Lancet Neurol 16:837\u2013847","journal-title":"Lancet Neurol"},{"key":"2555_CR391","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ymthe.2016.11.010","volume":"25","author":"AM Monteys","year":"2017","unstructured":"Monteys AM, Ebanks SA, Keiser MS, Davidson BL (2017) CRISPR\/Cas9 Editing of the Mutant Huntingtin Allele in Vitro and in Vivo. Mol Ther 25:12\u201323","journal-title":"Mol Ther"},{"key":"2555_CR392","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3233\/JHD-170266","volume":"7","author":"J Wu","year":"2018","unstructured":"Wu J, Ryskamp D, Birnbaumer L, Bezprozvanny I (2018) Inhibition of TRPC1-Dependent Store-Operated Calcium Entry Improves Synaptic Stability and Motor Performance in a Mouse Model of Huntington\u2019s Disease. J Huntingt Dis 7:35\u201350","journal-title":"J Huntingt Dis"},{"key":"2555_CR393","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1093\/nar\/gkf664","volume":"30","author":"J Lee","year":"2002","unstructured":"Lee J, Park EH, Couture G, Harvey I, Garneau P, Pelletier J (2002) An Upstream Open Reading Frame Impedes Translation of the Huntingtin Gene. Nucleic Acids Res 30:5110\u20135119","journal-title":"Nucleic Acids Res"},{"key":"2555_CR394","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1002\/humu.23580","volume":"39","author":"I H\u00f6ijer","year":"2018","unstructured":"H\u00f6ijer I, Tsai Y-C, Clark TA, Kotturi P, Dahl N, Stattin E-L, Bondeson M-L, Feuk L, Gyllensten U, Ameur A (2018) Detailed Analysis of HTT Repeat Elements in Human Blood Using Targeted Amplification-Free Long-Read Sequencing. Hum Mutat 39:1262\u20131272","journal-title":"Hum Mutat"},{"key":"2555_CR395","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2174\/156652310793180706","volume":"10","author":"AM Mitchell","year":"2010","unstructured":"Mitchell AM, Nicolson SC, Warischalk JK, Jude Samulski R (2010) AAV\u2019s Anatomy: Roadmap for Optimizing Vectors for Translational Success. Curr. Gene Ther. 10:319\u2013340","journal-title":"Curr. Gene Ther."},{"key":"2555_CR396","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nrg2971","volume":"12","author":"MA Kay","year":"2011","unstructured":"Kay MA (2011) State-of-the-Art Gene-Based Therapies: The Road Ahead. Nat Rev Genet 12:316\u2013328","journal-title":"Nat Rev Genet"},{"key":"2555_CR397","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1146\/annurev.bioeng.10.061807.160514","volume":"10","author":"DV Schaffer","year":"2008","unstructured":"Schaffer DV, Koerber JT, Lim K (2008) Molecular Engineering of Viral Gene Delivery Vehicles. Annu Rev Biomed Eng 10:169\u2013194","journal-title":"Annu Rev Biomed Eng"},{"key":"2555_CR398","first-page":"495","volume":"21","author":"M Cucchiarini","year":"2016","unstructured":"Cucchiarini M (2016) Human Gene Therapy: Novel Approaches to Improve the Current Gene Delivery Systems. Discov Med 21:495\u2013506","journal-title":"Discov Med"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02555-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-021-02555-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02555-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T13:01:49Z","timestamp":1744117309000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-021-02555-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":398,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["2555"],"URL":"https:\/\/doi.org\/10.1007\/s12035-021-02555-y","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,15]]},"assertion":[{"value":"24 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This manuscript is according to the ethical standards.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors agreed with the submitted version of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}